CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor |
|
Accession: | CHEBI:50781
|
browse the term
|
Definition: | An EC 1.3.1.* (oxidoreductase acting on CH-CH group of donor, NAD(+) or NADP(+) as acceptor) inhibitor that interferes with the action of of 3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+)), EC 1.3.1.22, the enzyme which converts testosterone (CHEBI:17347) into the more potent androgen 5alpha-dihydrotestosterone. |
Synonyms: | related_synonym: | 3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+)) inhibitor; 3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+)) inhibitors; 3-oxo-5alpha-steroid 4-dehydrogenase inhibitor; 3-oxo-5alpha-steroid 4-dehydrogenase inhibitors; 3-oxo-5alpha-steroid:NADP+ Delta(4)-oxidoreductase inhibitor; 3-oxo-5alpha-steroid:NADP+ Delta(4)-oxidoreductase inhibitors; 3-oxosteroid 5alpha-reductase inhibitor; 3-oxosteroid Delta4-dehydrogenase inhibitor; 4-ene-3-oxosteroid 5alpha-reductase inhibitor; 4-ene-5alpha-reductase inhibitor; 5alpha-oxidoreductase inhibitor; 5alpha-oxidoreductase inhibitors; 5alpha-reductase inhibitor; 5alpha-reductase inhibitors; Delta(4)-3-ketosteroid 5alpha-oxidoreductase inhibitor; Delta(4)-3-ketosteroid 5alpha-oxidoreductase inhibitors; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitors; EC 1.3.1.22 inhibitor; EC 1.3.1.22 inhibitors; cholest-4-en-3-one 5alpha-reductase inhibitor; cholestenone 5alpha-reductase inhibitor; cholestenone 5alpha-reductase inhibitors; reduced nicotinamide adenine dinucleotide phosphate:Delta(4)-3-ketosteroid 5alpha-oxidoreductase inhibitor; reduced nicotinamide adenine dinucleotide phosphate:Delta(4)-3-ketosteroid 5alpha-oxidoreductase inhibitors; steroid 5alpha-hydrogenase inhibitor; steroid 5alpha-hydrogenase inhibitors; steroid 5alpha-reductase inhibitor; steroid 5alpha-reductase inhibitors; testosterone 5alpha-reductase inhibitor; testosterone 5alpha-reductase inhibitors; testosterone Delta(4)-5alpha-reductase inhibitor; testosterone Delta(4)-5alpha-reductase inhibitors; testosterone Delta(4)-hydrogenase inhibitor; testosterone Delta(4)-hydrogenase inhibitors |
| xref: | Wikipedia:5-alpha-reductase_inhibitor |
|
|
|
G |
Ccnb1 |
cyclin B1 |
affects phosphorylation increases expression |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone affects the phosphorylation of CCNB1 protein 5,7,3'-trihydroxy-3,4'-dimethoxyflavone results in increased expression of CCNB1 protein |
CTD |
PMID:21229608 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdc25c |
cell division cycle 25C |
affects phosphorylation |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone affects the phosphorylation of CDC25C protein |
CTD |
PMID:21229608 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
affects phosphorylation |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone affects the phosphorylation of CDK1 protein |
CTD |
PMID:21229608 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone results in increased expression of CDKN1A protein |
CTD |
PMID:21229608 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Foxm1 |
forkhead box M1 |
affects phosphorylation |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone affects the phosphorylation of FOXM1 protein |
CTD |
PMID:21229608 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Smpd1 |
sphingomyelin phosphodiesterase 1 |
increases activity |
ISO |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone results in increased activity of SMPD1 protein |
CTD |
PMID:21229608 |
|
NCBI chr 1:159,892,946...159,896,789
Ensembl chr 1:159,892,859...159,896,794
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression multiple interactions |
ISO |
3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA 3',4',7-trihydroxyisoflavone inhibits the reaction [Epirubicin results in increased expression of ABCB1 mRNA]; Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA]; Ascorbic Acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA]; CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA] |
CTD |
PMID:22914566 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions decreases expression |
ISO |
3',4',7-trihydroxyisoflavone inhibits the reaction [Epirubicin results in increased expression of ABCC1 mRNA]; Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA]; Ascorbic Acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA]; CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA] |
CTD |
PMID:22914566 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions decreases expression |
ISO |
3',4',7-trihydroxyisoflavone inhibits the reaction [Epirubicin results in increased expression of ABCC2 mRNA]; Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA]; Ascorbic Acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA]; CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA] |
CTD |
PMID:22914566 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
3',4',7-trihydroxyisoflavone results in increased expression of BAX mRNA 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of BAX mRNA]; Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of BAX mRNA] |
CTD |
PMID:22914566 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity |
ISO |
3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of CASP3 mRNA]; Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased activity of CASP3 protein]; Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of CASP3 mRNA] |
CTD |
PMID:22914566 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression increases activity |
ISO |
3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA]; Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased activity of CASP9 protein]; Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of CASP9 mRNA] |
CTD |
PMID:22914566 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA]; CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA]; CAT protein inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA] |
CTD |
PMID:22914566 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of TP53 mRNA]; Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of TP53 mRNA] |
CTD |
PMID:22914566 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Adi1 |
acireductone dioxygenase 1 |
decreases expression |
ISO |
Dutasteride results in decreased expression of ADI1 mRNA |
CTD |
PMID:20564326 |
|
NCBI chr 6:45,306,885...45,313,847
Ensembl chr 6:45,306,841...45,313,842
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Dutasteride results in increased expression of AKR1C1 mRNA |
CTD |
PMID:16806904 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Dutasteride results in increased expression of AKR1C2 mRNA |
CTD |
PMID:16806904 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
Dutasteride results in increased expression of AKR1C3 mRNA |
CTD |
PMID:16806904 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Ar |
androgen receptor |
increases expression multiple interactions |
ISO |
Dutasteride results in increased expression of AR mRNA [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride] results in decreased expression of AR protein |
CTD |
PMID:17636412 PMID:24323034 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Calr |
calreticulin |
multiple interactions decreases expression |
ISO |
Dutasteride promotes the reaction [Testosterone results in increased expression of CALR mRNA] Dutasteride results in decreased expression of CALR mRNA |
CTD |
PMID:20564326 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
Dutasteride results in increased expression of CCND1 mRNA |
CTD |
PMID:17636412 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
increases expression |
ISO |
Dutasteride results in increased expression of CYP11B2 mRNA |
CTD |
PMID:17636412 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
Dutasteride results in decreased expression of DHCR24 mRNA |
CTD |
PMID:17636412 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Eaf2 |
ELL associated factor 2 |
multiple interactions decreases expression |
ISO |
Dutasteride promotes the reaction [Testosterone results in increased expression of EAF2 mRNA] Dutasteride results in decreased expression of EAF2 mRNA |
CTD |
PMID:20564326 |
|
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
increases expression |
ISO |
Dutasteride results in increased expression of ERBB2 mRNA |
CTD |
PMID:17636412 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
increases expression |
ISO |
Dutasteride results in increased expression of HSD17B1 mRNA |
CTD |
PMID:17636412 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
increases expression |
ISO |
Dutasteride results in increased expression of HSD17B3 mRNA |
CTD |
PMID:17636412 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
Dutasteride results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
decreases expression multiple interactions |
ISO |
Dutasteride results in decreased expression of KLK3 mRNA [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of KLK3 protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of KLK3 protein; [Goserelin co-treated with Dutasteride] results in decreased expression of KLK3 protein |
CTD |
PMID:17636412 PMID:20564326 PMID:24323034 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
increases expression |
ISO |
Dutasteride results in increased expression of SOS1 mRNA |
CTD |
PMID:17636412 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression decreases activity |
ISO |
Dutasteride results in decreased expression of SRD5A1 mRNA Dutasteride results in decreased activity of SRD5A1 protein |
CTD |
PMID:16806904 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases expression |
ISO |
Dutasteride results in decreased expression of SRD5A2 mRNA |
CTD |
PMID:16806904 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
increases expression |
ISO |
Dutasteride results in increased expression of VCAM1 mRNA |
CTD |
PMID:17636412 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
decreases expression |
EXP |
Finasteride results in decreased expression of ABAT protein |
CTD |
PMID:27750143 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity |
ISO |
Finasteride results in decreased activity of ABCB11 protein |
CTD |
PMID:20829430 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
increases expression |
EXP |
Finasteride results in increased expression of ABCB6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
increases expression |
EXP |
Finasteride results in increased expression of ABCD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
increases expression |
EXP |
Finasteride results in increased expression of ABCE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
|
|
G |
Abhd15 |
abhydrolase domain containing 15 |
increases expression |
EXP |
Finasteride results in increased expression of ABHD15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:62,363,209...62,368,600
Ensembl chr10:62,363,209...62,368,600
|
|
G |
Abhd16a |
abhydrolase domain containing 16A, phospholipase |
increases expression |
EXP |
Finasteride results in increased expression of ABHD16A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:3,719,089...3,733,952
Ensembl chr20:3,719,091...3,733,927
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
EXP |
Finasteride results in increased expression of ABHD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Abhd6 |
abhydrolase domain containing 6, acylglycerol lipase |
increases expression |
EXP |
Finasteride results in increased expression of ABHD6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985
|
|
G |
Abi1 |
abl-interactor 1 |
increases expression |
EXP |
Finasteride results in increased expression of ABI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
increases expression |
EXP |
Finasteride results in increased expression of ACAA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
EXP |
Finasteride results in increased expression of ACAA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
increases expression |
EXP |
Finasteride results in increased expression of ACAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
|
|
G |
Acd |
ACD, shelterin complex subunit and telomerase recruitment factor |
increases expression |
EXP |
Finasteride results in increased expression of ACD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:33,586,739...33,589,481
Ensembl chr19:33,586,745...33,589,461
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
increases expression |
EXP |
Finasteride results in increased expression of ACOT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
increases expression |
EXP |
Finasteride results in increased expression of ACOT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot3 |
acyl-CoA thioesterase 3 |
increases expression |
EXP |
Finasteride results in increased expression of ACOT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
|
|
G |
Acot7 |
acyl-CoA thioesterase 7 |
increases expression |
EXP |
Finasteride results in increased expression of ACOT7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
|
|
G |
Acot8 |
acyl-CoA thioesterase 8 |
increases expression |
EXP |
Finasteride results in increased expression of ACOT8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:153,531,192...153,542,851
Ensembl chr 3:153,531,193...153,542,851
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
EXP |
Finasteride results in increased expression of ACOX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acp3 |
acid phosphatase 3 |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Testosterone results in increased secretion of ACP3 protein] |
CTD |
PMID:27866977 |
|
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Testosterone results in increased expression of ACTA2 mRNA] |
CTD |
PMID:27866977 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actl6a |
actin-like 6A |
increases expression |
EXP |
Finasteride results in increased expression of ACTL6A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:115,492,374...115,508,401
Ensembl chr 2:115,492,285...115,508,401
|
|
G |
Actn4 |
actinin alpha 4 |
increases expression |
EXP |
Finasteride results in increased expression of ACTN4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
|
|
G |
Actr10 |
actin related protein 10 |
increases expression |
EXP |
Finasteride results in increased expression of ACTR10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:89,446,141...89,472,350
Ensembl chr 6:89,446,093...89,473,047
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
EXP |
Finasteride results in increased expression of ACY1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Add1 |
adducin 1 |
increases expression |
EXP |
Finasteride results in increased expression of ADD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Adipor2 |
adiponectin receptor 2 |
increases expression |
EXP |
Finasteride results in increased expression of ADIPOR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adsl |
adenylosuccinate lyase |
increases expression |
EXP |
Finasteride results in increased expression of ADSL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:112,479,256...112,503,439
Ensembl chr 7:112,479,271...112,503,760
|
|
G |
Adss2 |
adenylosuccinate synthase 2 |
increases expression |
EXP |
Finasteride results in increased expression of ADSS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604
|
|
G |
Agfg2 |
ArfGAP with FG repeats 2 |
increases expression |
EXP |
Finasteride results in increased expression of CCZ1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:19,012,228...19,048,433
Ensembl chr12:19,012,258...19,048,421
|
|
G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
increases expression |
EXP |
Finasteride results in increased expression of AGPAT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358
|
|
G |
Ahsa1 |
activator of Hsp90 ATPase activity 1 |
increases expression |
EXP |
Finasteride results in increased expression of AHSA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
|
|
G |
Aig1 |
androgen-induced 1 |
increases expression |
EXP |
Finasteride results in increased expression of AIG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:8,046,430...8,269,276
Ensembl chr 1:8,046,430...8,269,084
|
|
G |
Akap1 |
A-kinase anchoring protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of AKAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
increases expression |
EXP |
Finasteride results in increased expression of AKAP9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
Finasteride results in increased expression of AKR7A3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
Finasteride inhibits the reaction [testosterone enanthate results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:36015278 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
increases expression |
EXP |
Finasteride results in increased expression of AKT1S1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
increases expression |
EXP |
Finasteride results in increased expression of AKT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
increases expression |
EXP |
Finasteride results in increased expression of ALDH3A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Alg14 |
ALG14, UDP-N-acetylglucosaminyltransferase subunit |
increases expression |
EXP |
Finasteride results in increased expression of ALG14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:209,368,285...209,445,425
Ensembl chr 2:209,368,312...209,445,431
|
|
G |
Alg3 |
ALG3, alpha-1,3- mannosyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of ALG3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
|
|
G |
Alg9 |
ALG9, alpha-1,2-mannosyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of ALG9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:51,117,057...51,188,790
Ensembl chr 8:51,119,365...51,182,261
|
|
G |
Alkbh2 |
alkB homolog 2, alpha-ketoglutarate-dependent dioxygenase |
increases expression |
EXP |
Finasteride results in increased expression of ALKBH2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:42,494,187...42,500,929
Ensembl chr12:42,496,300...42,500,914
|
|
G |
Amd1 |
adenosylmethionine decarboxylase 1 |
increases expression |
EXP |
Finasteride results in increased expression of AMD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
|
|
G |
Ammecr1l |
AMMECR1 like |
increases expression |
EXP |
Finasteride results in increased expression of AMMECR1L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:23,386,114...23,411,177
Ensembl chr18:23,386,903...23,410,920
|
|
G |
Amt |
aminomethyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of AMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,981,620...108,988,127
Ensembl chr 8:108,976,472...108,988,126
|
|
G |
Amz2 |
archaelysin family metallopeptidase 2 |
increases expression |
EXP |
Finasteride results in increased expression of AMZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:94,401,546...94,412,116
Ensembl chr10:94,401,579...94,412,114
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
increases expression |
EXP |
Finasteride results in increased expression of ANAPC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Anapc4 |
anaphase promoting complex subunit 4 |
increases expression |
EXP |
Finasteride results in increased expression of ANAPC4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:58,125,995...58,159,253
Ensembl chr14:58,125,995...58,157,770
|
|
G |
Ankrd24 |
ankyrin repeat domain 24 |
increases expression |
EXP |
Finasteride results in increased expression of ANKRD24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142
|
|
G |
Ankrd28 |
ankyrin repeat domain 28 |
increases expression |
EXP |
Finasteride results in increased expression of ANKRD28 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,918,487...7,050,244
Ensembl chr16:6,914,336...7,050,249
|
|
G |
Ano10 |
anoctamin 10 |
increases expression |
EXP |
Finasteride results in increased expression of ANO10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:121,841,664...121,960,739
Ensembl chr 8:121,841,665...121,962,670
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
increases expression |
EXP |
Finasteride results in increased expression of ANP32A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Anxa7 |
annexin A7 |
increases expression |
EXP |
Finasteride results in increased expression of ANXA7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
|
|
G |
Ap1ar |
adaptor-related protein complex 1 associated regulatory protein |
increases expression |
EXP |
Finasteride results in increased expression of AP1AR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:216,276,631...216,309,020
Ensembl chr 2:216,276,631...216,309,013
|
|
G |
Ap1m1 |
adaptor related protein complex 1 subunit mu 1 |
increases expression |
EXP |
Finasteride results in increased expression of AP1M1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:17,586,886...17,602,410
Ensembl chr16:17,584,730...17,602,403
|
|
G |
Ap3d1 |
adaptor related protein complex 3 subunit delta 1 |
increases expression |
EXP |
Finasteride results in increased expression of AP3D1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,970,249...9,005,651
Ensembl chr 7:8,970,291...9,005,643
|
|
G |
Apool |
apolipoprotein O-like |
increases expression |
EXP |
Finasteride results in increased expression of APOOL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:77,377,723...77,443,672
Ensembl chr X:77,377,781...77,443,900
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
EXP |
Finasteride results in increased expression of APP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of AQP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp8 |
aquaporin 8 |
increases expression |
EXP |
Finasteride results in increased expression of AQP8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO EXP |
Finasteride inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Finasteride inhibits the reaction [Metribolone results in increased activity of AR protein] Finasteride inhibits the reaction [Testosterone results in increased expression of AR mRNA]; Finasteride inhibits the reaction [Testosterone results in increased expression of AR protein] |
CTD |
PMID:18324785 PMID:27687055 PMID:27866977 PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgap12 |
Rho GTPase activating protein 12 |
increases expression |
EXP |
Finasteride results in increased expression of ARHGAP12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:51,588,810...51,702,417
Ensembl chr17:51,588,842...51,702,080
|
|
G |
Arhgef18 |
Rho/Rac guanine nucleotide exchange factor 18 |
increases expression |
EXP |
Finasteride results in increased expression of ARHGEF18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:1,395,035...1,503,082
Ensembl chr12:1,395,088...1,503,081
|
|
G |
Arid1b |
AT-rich interaction domain 1B |
decreases expression |
EXP |
Finasteride results in decreased expression of ARID1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
|
|
G |
Arl1 |
ADP-ribosylation factor like GTPase 1 |
increases expression |
EXP |
Finasteride results in increased expression of ARL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Arl6ip1 |
ADP-ribosylation factor like GTPase 6 interacting protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of ARL6IP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
|
|
G |
Armc1 |
armadillo repeat containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of ARMC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:101,608,171...101,652,198
Ensembl chr 2:101,608,288...101,652,171
|
|
G |
Arpc5l |
actin related protein 2/3 complex, subunit 5-like |
increases expression |
EXP |
Finasteride results in increased expression of ARPC5L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:22,758,710...22,767,520
Ensembl chr 3:22,759,876...22,767,538 Ensembl chr 9:22,759,876...22,767,538
|
|
G |
Arpin |
actin-related protein 2/3 complex inhibitor |
increases expression |
EXP |
Finasteride results in increased expression of ARPIN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:133,864,288...133,873,124
Ensembl chr 1:133,864,265...133,873,124
|
|
G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
increases expression |
EXP |
Finasteride results in increased expression of ARPP19 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:75,779,640...75,802,474
Ensembl chr 8:75,779,523...75,802,452 Ensembl chr 8:75,779,523...75,802,452
|
|
G |
Ash2l |
ASH2 like histone lysine methyltransferase complex subunit |
increases expression |
EXP |
Finasteride results in increased expression of ASH2L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:66,242,205...66,264,064
Ensembl chr16:66,242,212...66,264,061
|
|
G |
Asnsd1 |
asparagine synthetase domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of ASNSD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:48,126,808...48,139,073
Ensembl chr 9:48,126,808...48,139,073
|
|
G |
Ate1 |
arginyltransferase 1 |
increases expression |
EXP |
Finasteride results in increased expression of ATE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:184,961,548...185,081,112
Ensembl chr 1:184,963,562...185,080,908
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
EXP |
Finasteride results in increased expression of ATG3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Atp11a |
ATPase phospholipid transporting 11A |
increases expression |
EXP |
Finasteride results in increased expression of ATP11A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:76,657,752...76,767,640
Ensembl chr16:76,657,752...76,767,640
|
|
G |
Atp5if1 |
ATP synthase inhibitory factor subunit 1 |
increases expression |
EXP |
Finasteride results in increased expression of ATP5IF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
|
|
G |
Atp6ap2 |
ATPase H+ transporting accessory protein 2 |
increases expression |
EXP |
Finasteride results in increased expression of ATP6AP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:10,183,983...10,210,948
Ensembl chr X:10,183,068...10,210,918
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
increases expression |
EXP |
Finasteride results in increased expression of ATP6V1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
|
|
G |
Atp6v1c1 |
ATPase H+ transporting V1 subunit C1 |
increases expression |
EXP |
Finasteride results in increased expression of ATP6V1C1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
increases expression |
EXP |
Finasteride results in increased expression of ATP6V1D mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
Atp6v1e1 |
ATPase H+ transporting V1 subunit E1 |
increases expression |
EXP |
Finasteride results in increased expression of ATP6V1E1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:154,022,358...154,044,486
Ensembl chr 4:154,022,358...154,044,584
|
|
G |
Atp6v1g1 |
ATPase H+ transporting V1 subunit G1 |
increases expression |
EXP |
Finasteride results in increased expression of ATP6V1G1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:76,961,462...76,967,642
Ensembl chr 5:76,961,499...76,969,463
|
|
G |
Atxn10 |
ataxin 10 |
increases expression |
EXP |
Finasteride results in increased expression of ATXN10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:116,441,768...116,565,093
Ensembl chr 7:116,441,613...116,565,087
|
|
G |
Aup1 |
AUP1, lipid droplet regulating VLDL assembly factor |
increases expression |
EXP |
Finasteride results in increased expression of AUP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,560,274...115,563,346
Ensembl chr 4:115,560,261...115,563,346
|
|
G |
Aurkaip1 |
aurora kinase A interacting protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of AURKAIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:166,435,177...166,436,888
Ensembl chr 5:166,417,508...166,436,882
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of B4GALT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
[Finasteride co-treated with Testosterone] results in increased expression of BAX protein; Finasteride inhibits the reaction [testosterone enanthate results in decreased expression of BAX mRNA]; Finasteride inhibits the reaction [testosterone enanthate results in decreased expression of BAX protein]; Finasteride inhibits the reaction [Testosterone results in decreased expression of BAX protein] |
CTD |
PMID:25714330 PMID:27687055 PMID:27866977 PMID:36015278 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbs2 |
Bardet-Biedl syndrome 2 |
increases expression |
EXP |
Finasteride results in increased expression of BBS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,909,653...10,944,998
Ensembl chr19:10,909,619...10,944,993
|
|
G |
Bcap29 |
B-cell receptor-associated protein 29 |
increases expression |
EXP |
Finasteride results in increased expression of BCAP29 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:48,182,702...48,222,698
Ensembl chr 6:48,182,706...48,222,720
|
|
G |
Bcap31 |
B-cell receptor-associated protein 31 |
increases expression |
EXP |
Finasteride results in increased expression of BCAP31 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:151,397,567...151,429,666
Ensembl chr X:151,397,576...151,428,506
|
|
G |
Bccip |
BRCA2 and CDKN1A interacting protein |
increases expression |
EXP |
Finasteride results in increased expression of BCCIP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:188,512,544...188,524,957
Ensembl chr 1:188,512,367...188,524,958
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP |
Finasteride inhibits the reaction [testosterone enanthate results in increased expression of BCL2 mRNA]; Finasteride inhibits the reaction [testosterone enanthate results in increased expression of BCL2 protein]; Finasteride inhibits the reaction [Testosterone results in increased expression of BCL2 protein]; Hesperidin inhibits the reaction [Finasteride results in decreased expression of BCL2 mRNA] |
CTD |
PMID:25714330 PMID:27687055 PMID:27866977 PMID:36015278 PMID:38216069 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein] |
CTD |
PMID:25714330 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l13 |
Bcl2-like 13 |
increases expression |
EXP |
Finasteride results in increased expression of BCL2L13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:154,056,116...154,112,890
Ensembl chr 4:154,056,127...154,108,985
|
|
G |
Bcs1l |
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone |
increases expression |
EXP |
Finasteride results in increased expression of BCS1L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:76,164,925...76,168,940
Ensembl chr 9:76,164,932...76,168,938
|
|
G |
Blmh |
bleomycin hydrolase |
increases expression |
EXP |
Finasteride results in increased expression of BLMH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:61,772,112...61,815,212
Ensembl chr10:61,758,478...61,815,212
|
|
G |
Bloc1s5 |
biogenesis of lysosomal organelles complex 1 subunit 5 |
increases expression |
EXP |
Finasteride results in increased expression of BLOC1S5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:26,171,965...26,197,276
Ensembl chr17:26,172,018...26,197,251
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
EXP |
Finasteride results in increased expression of BLVRB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
increases expression |
EXP |
Finasteride results in increased expression of BMP7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
increases expression |
EXP |
Finasteride results in increased expression of BNIP3L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Bola3 |
bolA family member 3 |
increases expression |
EXP |
Finasteride results in increased expression of BOLA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:115,853,350...115,862,797
|
|
G |
Borcs7 |
BLOC-1 related complex subunit 7 |
increases expression |
EXP |
Finasteride results in increased expression of BORCS7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:245,564,347...245,578,182
Ensembl chr 1:245,564,369...245,579,343
|
|
G |
Brd9 |
bromodomain containing 9 |
increases expression |
EXP |
Finasteride results in increased expression of BRD9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:29,329,981...29,357,285
Ensembl chr 1:29,329,985...29,357,016
|
|
G |
Btbd1 |
BTB domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of BTBD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:135,734,549...135,773,067
Ensembl chr 1:135,734,589...135,771,981
|
|
G |
Bud31 |
BUD31 homolog |
increases expression |
EXP |
Finasteride results in increased expression of BUD31 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:9,462,838...9,470,387
Ensembl chr12:9,462,441...9,470,509
|
|
G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
increases expression |
EXP |
Finasteride results in increased expression of BZW1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
|
|
G |
C10h17orf58 |
similar to human chromosome 17 open reading frame 58 |
increases expression |
EXP |
Finasteride results in increased expression of C10H17ORF58 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602
|
|
G |
C10h5orf15 |
similar to human chromosome 5 open reading frame 15 |
increases expression |
EXP |
Finasteride results in increased expression of C10H5ORF15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:36,563,989...36,576,593
Ensembl chr10:36,563,958...36,576,590
|
|
G |
C17h7orf25 |
similar to human chromosome 7 open reading frame 25 |
increases expression |
EXP |
Finasteride results in increased expression of C17H7ORF25 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:50,543,231...50,549,880
Ensembl chr17:50,542,858...50,549,976
|
|
G |
C18h18orf32 |
similar to human chromosome 18 open reading frame 32 |
increases expression |
EXP |
Finasteride results in increased expression of C18H18ORF32 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:68,586,278...68,594,851
Ensembl chr18:68,586,211...68,596,787
|
|
G |
C19h1orf131 |
similar to human chromosome 1 open reading frame 131 |
increases expression |
EXP |
Finasteride results in increased expression of C19H1ORF131 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:52,807,932...52,822,259
Ensembl chr19:52,807,934...52,822,267
|
|
G |
C1galt1c1 |
C1GALT1-specific chaperone 1 |
increases expression |
EXP |
Finasteride results in increased expression of C1GALT1C1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:117,378,123...117,382,620
Ensembl chr X:117,375,525...117,382,787
|
|
G |
C20h6orf89 |
similar to human chromosome 6 open reading frame 89 |
increases expression |
EXP |
Finasteride results in increased expression of C20H6ORF89 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:7,322,483...7,362,054
Ensembl chr20:7,322,442...7,357,612
|
|
G |
C4b |
complement C4B |
decreases expression |
EXP |
Finasteride results in decreased expression of C4B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
C5h1orf174 |
similar to human chromosome 1 open reading frame 174 |
increases expression |
EXP |
Finasteride results in increased expression of C5H1ORF174 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:164,515,578...164,520,022
Ensembl chr 5:164,515,559...164,520,021
|
|
G |
Cab39l |
calcium binding protein 39-like |
increases expression |
EXP |
Finasteride results in increased expression of CAB39L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:33,606,588...33,710,518
Ensembl chr15:33,606,694...33,743,545
|
|
G |
Cacybp |
calcyclin binding protein |
increases expression |
EXP |
Finasteride results in increased expression of CACYBP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
EXP |
Finasteride results in increased expression of CADM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calm3 |
calmodulin 3 |
increases expression |
EXP |
Finasteride results in increased expression of CALM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Caprin1 |
cell cycle associated protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of CAPRIN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
Finasteride results in increased expression of CASP3 mRNA Finasteride inhibits the reaction [Testosterone results in decreased expression of CASP3 protein modified form]; Finasteride inhibits the reaction [Testosterone results in increased expression of CASP3 protein]; Hesperidin inhibits the reaction [Finasteride results in increased expression of CASP3 mRNA] |
CTD |
PMID:24136188 PMID:25714330 PMID:27687055 PMID:38216069 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cast |
calpastatin |
increases expression |
EXP |
Finasteride results in increased expression of CAST mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
EXP |
Finasteride inhibits the reaction [Testosterone results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Finasteride results in decreased activity of CAT protein] |
CTD |
PMID:27866977 PMID:33003968 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cavin3 |
caveolae associated protein 3 |
increases expression |
EXP |
Finasteride results in increased expression of CAVIN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Cbx3 |
chromobox 3 |
increases expression |
EXP |
Finasteride results in increased expression of CBX3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283
|
|
G |
Ccdc22 |
coiled-coil domain containing 22 |
increases expression |
EXP |
Finasteride results in increased expression of CCDC22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:14,898,296...14,910,244
Ensembl chr X:14,898,296...14,910,244
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
EXP |
Finasteride inhibits the reaction [testosterone enanthate results in increased expression of CCND1 protein] |
CTD |
PMID:36015278 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
EXP |
Finasteride results in increased expression of CCNG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccnq |
cyclin Q |
increases expression |
EXP |
Finasteride results in increased expression of CCNQ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:63,646,532...63,647,695
Ensembl chr10:63,646,527...63,647,961
|
|
G |
Ccny |
cyclin Y |
increases expression |
EXP |
Finasteride results in increased expression of CCNY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:57,385,002...57,512,860
Ensembl chr17:57,384,176...57,522,378
|
|
G |
Cct2 |
chaperonin containing TCP1 subunit 2 |
increases expression |
EXP |
Finasteride results in increased expression of CCT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:52,692,725...52,705,478
Ensembl chr 7:52,692,725...52,706,944
|
|
G |
Cct3 |
chaperonin containing TCP1 subunit 3 |
increases expression |
EXP |
Finasteride results in increased expression of CCT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:173,765,701...173,790,353
Ensembl chr 2:173,765,698...173,790,757
|
|
G |
Cct4 |
chaperonin containing TCP1 subunit 4 |
increases expression |
EXP |
Finasteride results in increased expression of CCT4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:96,991,853...97,004,732
Ensembl chr14:96,991,859...97,005,267
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
increases expression |
EXP |
Finasteride results in increased expression of CCT5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cct6a |
chaperonin containing TCP1 subunit 6A |
increases expression |
EXP |
Finasteride results in increased expression of CCT6A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:26,872,736...26,883,125
Ensembl chr12:26,872,574...26,883,337
|
|
G |
Cct8 |
chaperonin containing TCP1 subunit 8 |
increases expression |
EXP |
Finasteride results in increased expression of CCT8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
|
|
G |
Cdc37l1 |
cell division cycle 37-like 1 |
increases expression |
EXP |
Finasteride results in increased expression of CDC37L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Testosterone results in decreased expression of CDH1 mRNA] |
CTD |
PMID:27866977 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk2ap1 |
cyclin-dependent kinase 2 associated protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of CDK2AP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:32,249,752...32,258,483
Ensembl chr12:32,249,747...32,258,479
|
|
G |
Celf1 |
CUGBP, Elav-like family member 1 |
increases expression |
EXP |
Finasteride results in increased expression of CELF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:76,924,591...76,999,429
Ensembl chr 3:76,924,613...76,999,426
|
|
G |
Cenpl |
centromere protein L |
increases expression |
EXP |
Finasteride results in increased expression of CENPL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
|
|
G |
Cenpv |
centromere protein V |
increases expression |
EXP |
Finasteride results in increased expression of CENPV mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:47,214,479...47,228,552
Ensembl chr10:47,214,490...47,228,761
|
|
G |
Cep15 |
centrosomal protein 15 |
increases expression |
EXP |
Finasteride results in increased expression of CEP15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:12,815,159...12,835,115
Ensembl chr15:12,818,385...12,833,838
|
|
G |
Ces2h |
carboxylesterase 2H |
increases expression |
EXP |
Finasteride results in increased expression of CES2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cfap298 |
cilia and flagella associated protein 298 |
increases expression |
EXP |
Finasteride results in increased expression of CFAP298 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:30,181,916...30,191,302
Ensembl chr11:30,181,905...30,191,346
|
|
G |
Cfap36 |
cilia and flagella associated protein 36 |
increases expression |
EXP |
Finasteride results in increased expression of CFAP36 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:102,966,006...102,991,693
Ensembl chr14:102,966,001...102,991,555
|
|
G |
Cfdp1 |
craniofacial development protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of CFDP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:39,718,313...39,823,824
Ensembl chr19:39,718,347...39,823,824
|
|
G |
Cfl1 |
cofilin 1 |
increases expression |
EXP |
Finasteride results in increased expression of CFL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Cfl2 |
cofilin 2 |
increases expression |
EXP |
Finasteride results in increased expression of CFL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:72,355,664...72,359,709
Ensembl chr 6:72,355,664...72,359,674
|
|
G |
Chchd3 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
increases expression |
EXP |
Finasteride results in increased expression of CHCHD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:61,360,352...61,616,850
Ensembl chr 4:61,360,353...61,616,847
|
|
G |
Chchd5 |
coiled-coil-helix-coiled-coil-helix domain containing 5 |
increases expression |
EXP |
Finasteride results in increased expression of CHCHD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:116,361,845...116,372,238
Ensembl chr 3:116,361,885...116,367,169
|
|
G |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
increases expression |
EXP |
Finasteride results in increased expression of CHCHD6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216
|
|
G |
Chd8 |
chromodomain helicase DNA binding protein 8 |
increases expression |
EXP |
Finasteride results in increased expression of CHD8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
|
|
G |
Chkb |
choline kinase beta |
increases expression |
EXP |
Finasteride results in increased expression of CHKB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:120,500,960...120,504,359
Ensembl chr 7:120,500,984...120,504,461
|
|
G |
Chmp2a |
charged multivesicular body protein 2A |
increases expression |
EXP |
Finasteride results in increased expression of CHMP2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:73,660,045...73,662,894
Ensembl chr 1:73,660,046...73,662,452
|
|
G |
Chn2 |
chimerin 2 |
increases expression |
EXP |
Finasteride results in increased expression of CHN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709
|
|
G |
Chrac1 |
chromatin accessibility complex subunit 1 |
increases expression |
EXP |
Finasteride results in increased expression of CHRAC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:105,013,047...105,016,435
Ensembl chr 7:105,013,015...105,017,136
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
EXP |
Finasteride results in increased expression of CISD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
|
|
G |
Cisd3 |
CDGSH iron sulfur domain 3 |
increases expression |
EXP |
Finasteride results in increased expression of CISD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:82,679,345...82,682,376
Ensembl chr10:82,679,196...82,682,550
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of CLIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:32,910,932...33,017,891
Ensembl chr12:32,910,977...33,017,884
|
|
G |
Cln5 |
CLN5, intracellular trafficking protein |
increases expression |
EXP |
Finasteride results in increased expression of CLN5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:79,893,573...79,903,438
Ensembl chr15:79,893,548...79,903,438
|
|
G |
Clpb |
ClpB family mitochondrial disaggregase |
increases expression |
EXP |
Finasteride results in increased expression of CLPB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:156,028,740...156,158,183
Ensembl chr 1:156,028,930...156,168,788
|
|
G |
Clpp |
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
increases expression |
EXP |
Finasteride results in increased expression of CLPP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,831,680...1,837,700
Ensembl chr 9:1,830,311...1,837,693
|
|
G |
Cltb |
clathrin, light chain B |
increases expression |
EXP |
Finasteride results in increased expression of CLTB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
increases expression |
EXP |
Finasteride results in increased expression of CMTM6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:114,422,934...114,441,034
Ensembl chr 8:114,422,921...114,441,033
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
increases expression |
EXP |
Finasteride results in increased expression of CNDP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Cngb1 |
cyclic nucleotide gated channel subunit beta 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of CNGB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173
|
|
G |
Cnih1 |
cornichon family member 1 |
increases expression |
EXP |
Finasteride results in increased expression of CNIH1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:20,037,885...20,049,857
Ensembl chr15:20,037,885...20,049,761
|
|
G |
Cnih4 |
cornichon family member 4 |
increases expression |
EXP |
Finasteride results in increased expression of CNIH4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:92,910,315...92,926,428
Ensembl chr13:92,910,315...92,927,853
|
|
G |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
increases expression |
EXP |
Finasteride results in increased expression of CNOT6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:33,978,785...34,031,025
Ensembl chr10:33,980,831...34,031,025
|
|
G |
Coa3 |
cytochrome C oxidase assembly factor 3 |
increases expression |
EXP |
Finasteride results in increased expression of COA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:86,220,192...86,221,173
Ensembl chr10:86,220,194...86,221,178
|
|
G |
Coa5 |
cytochrome C oxidase assembly factor 5 |
increases expression |
EXP |
Finasteride results in increased expression of COA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:39,651,459...39,664,870
|
|
G |
Cog7 |
component of oligomeric golgi complex 7 |
increases expression |
EXP |
Finasteride results in increased expression of COG7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:176,489,795...176,549,455
Ensembl chr 1:176,489,791...176,549,455
|
|
G |
Colq |
collagen like tail subunit of asymmetric acetylcholinesterase |
increases expression |
EXP |
Finasteride results in increased expression of COLQ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
|
|
G |
Commd10 |
COMM domain containing 10 |
increases expression |
EXP |
Finasteride results in increased expression of COMMD10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:39,741,219...39,874,801
Ensembl chr18:39,741,298...39,874,903
|
|
G |
Commd3 |
COMM domain containing 3 |
increases expression |
EXP |
Finasteride results in increased expression of COMMD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177
|
|
G |
Commd5 |
COMM domain containing 5 |
increases expression |
EXP |
Finasteride results in increased expression of COMMD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Commd6 |
COMM domain containing 6 |
increases expression |
EXP |
Finasteride results in increased expression of COMMD6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:78,467,333...78,474,382
Ensembl chr15:78,467,804...78,474,382
|
|
G |
Commd8 |
COMM domain containing 8 |
increases expression |
EXP |
Finasteride results in increased expression of COMMD8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:36,049,040...36,059,617
Ensembl chr14:36,049,004...36,059,617
|
|
G |
Comtd1 |
catechol-O-methyltransferase domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of COMTD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895
|
|
G |
Cops4 |
COP9 signalosome subunit 4 |
increases expression |
EXP |
Finasteride results in increased expression of COPS4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:9,078,579...9,108,788
Ensembl chr14:9,078,576...9,108,887
|
|
G |
Cops5 |
COP9 signalosome subunit 5 |
increases expression |
EXP |
Finasteride results in increased expression of COPS5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
|
|
G |
Cops7a |
COP9 signalosome subunit 7A |
increases expression |
EXP |
Finasteride results in increased expression of COPS7A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:157,766,626...157,792,632
Ensembl chr 4:157,766,588...157,773,948
|
|
G |
Coq3 |
coenzyme Q3 methyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of COQ3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:35,429,567...35,460,613
Ensembl chr 5:35,429,574...35,460,607
|
|
G |
Coq5 |
coenzyme Q5, methyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of COQ5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:41,316,922...41,333,855
Ensembl chr12:41,316,748...41,333,848
|
|
G |
Coq6 |
coenzyme Q6 monooxygenase |
increases expression |
EXP |
Finasteride results in increased expression of COQ6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:104,007,814...104,019,888
Ensembl chr 6:104,007,872...104,024,657
|
|
G |
Coq9 |
coenzyme Q9 |
increases expression |
EXP |
Finasteride results in increased expression of COQ9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,166,948...10,179,976
Ensembl chr19:10,166,951...10,179,949
|
|
G |
Cox15 |
cytochrome c oxidase assembly homolog COX15 |
increases expression |
EXP |
Finasteride results in increased expression of COX15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:242,605,588...242,622,279
Ensembl chr 1:242,605,588...242,622,261
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
increases expression |
EXP |
Finasteride results in increased expression of COX17 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cox19 |
cytochrome c oxidase assembly factor COX19 |
increases expression |
EXP |
Finasteride results in increased expression of COX19 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:15,303,535...15,313,014
Ensembl chr12:15,303,551...15,313,014
|
|
G |
Cpox |
coproporphyrinogen oxidase |
increases expression |
EXP |
Finasteride results in increased expression of CPOX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:41,936,585...41,946,568
Ensembl chr11:41,936,591...41,946,746
|
|
G |
Cpped1 |
calcineurin-like phosphoesterase domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of CPPED1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054
|
|
G |
Cpsf3 |
cleavage and polyadenylation specific factor 3 |
increases expression |
EXP |
Finasteride results in increased expression of CPSF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:40,836,121...40,864,129
Ensembl chr 6:40,836,097...40,864,128
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
increases expression |
EXP |
Finasteride results in increased expression of CPT1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
EXP |
Finasteride results in increased expression of CPT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crat |
carnitine O-acetyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of CRAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
increases expression |
EXP |
Finasteride results in increased expression of CREB3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:57,817,865...57,823,233
Ensembl chr 5:57,817,832...57,824,390
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
increases expression |
EXP |
Finasteride results in increased expression of CREB3L3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
|
|
G |
Crebzf |
CREB/ATF bZIP transcription factor |
increases expression |
EXP |
Finasteride results in increased expression of CREBZF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
increases expression |
EXP |
Finasteride results in increased expression of CREG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
ISO |
[Finasteride results in increased susceptibility to IL1B protein] which results in increased expression of CRH mRNA |
CTD |
PMID:19458216 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
decreases expression |
EXP |
Finasteride results in decreased expression of CRY2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Cryl1 |
crystallin, lambda 1 |
increases expression |
EXP |
Finasteride results in increased expression of CRYL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Cs |
citrate synthase |
increases expression |
EXP |
Finasteride results in increased expression of CS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
increases expression |
EXP |
Finasteride results in increased expression of CSAD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
|
|
G |
Csde1 |
cold shock domain containing E1 |
increases expression |
EXP |
Finasteride results in increased expression of CSDE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:190,546,015...190,582,787
Ensembl chr 2:190,554,980...190,582,784
|
|
G |
Csf1 |
colony stimulating factor 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of CSF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
increases expression |
EXP |
Finasteride results in increased expression of CSNK2A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Ctnnbl1 |
catenin, beta like 1 |
increases expression |
EXP |
Finasteride results in increased expression of CTNNBL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:146,387,940...146,548,987
Ensembl chr 3:146,387,889...146,548,987
|
|
G |
Ctps2 |
CTP synthase 2 |
increases expression |
EXP |
Finasteride results in increased expression of CTPS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:31,645,873...31,786,733
Ensembl chr X:31,645,873...31,786,733
|
|
G |
Cyb561d2 |
cytochrome b561 family, member D2 |
increases expression |
EXP |
Finasteride results in increased expression of CYB561D2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,213,201...108,215,778
Ensembl chr 8:108,213,205...108,215,759
|
|
G |
Cyb5r4 |
cytochrome b5 reductase 4 |
increases expression |
EXP |
Finasteride results in increased expression of CYB5R4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Finasteride promotes the reaction [Androstenedione results in increased expression of CYP11A1 mRNA]; Finasteride promotes the reaction [Testosterone results in increased expression of CYP11A1 mRNA] |
CTD |
PMID:21273442 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions |
EXP ISO |
Finasteride promotes the reaction [Androstenedione results in increased expression of CYP19A1 mRNA]; Finasteride promotes the reaction [Testosterone results in increased expression of CYP19A1 mRNA] [Finasteride co-treated with Testosterone] results in increased expression of CYP19A1 mRNA; Finasteride promotes the reaction [[tributyltin co-treated with Testosterone] results in increased expression of CYP19A1 mRNA]; tributyltin promotes the reaction [[Finasteride co-treated with Testosterone] results in increased expression of CYP19A1 mRNA] |
CTD |
PMID:21273442 PMID:23523586 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases expression |
EXP |
Finasteride results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp20a1 |
cytochrome P450, family 20, subfamily a, polypeptide 1 |
increases expression |
EXP |
Finasteride results in increased expression of CYP20A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:61,755,804...61,805,123
Ensembl chr 9:61,755,790...61,805,123
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
EXP |
Finasteride results in increased expression of CYP2B3 protein |
CTD |
PMID:27750143 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c24 |
cytochrome P450, family 2, subfamily c, polypeptide 24 |
decreases expression |
EXP |
Finasteride results in decreased expression of CYP2C55 protein |
CTD |
PMID:27750143 |
|
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
increases expression |
EXP |
Finasteride results in increased expression of CYP2F4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Dag1 |
dystroglycan 1 |
increases expression |
EXP |
Finasteride results in increased expression of DAG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325
|
|
G |
Daglb |
diacylglycerol lipase, beta |
increases expression |
EXP |
Finasteride results in increased expression of DAGLB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:11,059,732...11,102,170
Ensembl chr12:11,059,732...11,102,154
|
|
G |
Dars1 |
aspartyl-tRNA synthetase 1 |
increases expression |
EXP |
Finasteride results in increased expression of DARS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:39,857,936...39,913,055
Ensembl chr13:39,857,936...39,913,116
|
|
G |
Dars2 |
aspartyl-tRNA synthetase 2 (mitochondrial) |
increases expression |
EXP |
Finasteride results in increased expression of DARS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:73,308,726...73,336,558
Ensembl chr13:73,308,726...73,336,934
|
|
G |
Dbi |
diazepam binding inhibitor |
increases expression |
EXP |
Finasteride results in increased expression of DBI mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dcaf13 |
DDB1 and CUL4 associated factor 13 |
increases expression |
EXP |
Finasteride results in increased expression of DCAF13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:70,160,983...70,196,142
Ensembl chr 7:70,160,941...70,196,142
|
|
G |
Dctn5 |
dynactin subunit 5 |
increases expression |
EXP |
Finasteride results in increased expression of DCTN5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:176,689,176...176,705,907
Ensembl chr 1:176,689,156...176,705,906
|
|
G |
Ddx1 |
DEAD-box helicase 1 |
increases expression |
EXP |
Finasteride results in increased expression of DDX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365
|
|
G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
increases expression |
EXP |
Finasteride results in increased expression of DEGS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
|
|
G |
Dele1 |
DAP3 binding cell death enhancer 1 |
increases expression |
EXP |
Finasteride results in increased expression of DELE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:30,085,093...30,098,105
Ensembl chr18:30,085,126...30,098,756
|
|
G |
Denr |
density regulated reinitiation and release factor |
increases expression |
EXP |
Finasteride results in increased expression of DENR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:32,662,512...32,685,283
Ensembl chr12:32,662,516...32,683,843
|
|
G |
Desi2 |
desumoylating isopeptidase 2 |
increases expression |
EXP |
Finasteride results in increased expression of DESI2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416
|
|
G |
Dhdds |
dehydrodolichyl diphosphate synthase subunit |
increases expression |
EXP |
Finasteride results in increased expression of DHDDS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:146,198,359...146,224,479
Ensembl chr 5:146,197,457...146,224,454
|
|
G |
Dhrs13 |
dehydrogenase/reductase 13 |
increases expression |
EXP |
Finasteride results in increased expression of DHRS13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:62,920,791...62,925,952
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
increases expression |
EXP |
Finasteride results in increased expression of DHRS4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
increases expression |
EXP |
Finasteride results in increased expression of DHRS7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Dhrsx |
dehydrogenase/reductase X-linked |
increases expression |
EXP |
Finasteride results in increased expression of DHRSX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:16,299,768...16,304,553
Ensembl chr12:16,299,808...16,304,552
|
|
G |
Dhx36 |
DEAH-box helicase 36 |
increases expression |
EXP |
Finasteride results in increased expression of DHX36 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572
|
|
G |
Diaph1 |
diaphanous-related formin 1 |
increases expression |
EXP |
Finasteride results in increased expression of DIAPH1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:29,669,659...29,769,070
Ensembl chr18:29,669,659...29,769,172
|
|
G |
Dip2c |
disco-interacting protein 2 homolog C |
increases expression |
EXP |
Finasteride results in increased expression of DIP2C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
increases expression |
EXP |
Finasteride results in increased expression of DKC1 mRNA |
CTD |
PMID:24136188 |
|
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of DLG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Dmac2l |
distal membrane arm assembly component 2 like |
increases expression |
EXP |
Finasteride results in increased expression of DMAC2L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933
|
|
G |
Dmap1 |
DNA methyltransferase 1-associated protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of DMAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:131,143,726...131,151,760
Ensembl chr 5:131,143,729...131,151,742
|
|
G |
Dnajb12 |
DnaJ heat shock protein family (Hsp40) member B12 |
increases expression |
EXP |
Finasteride results in increased expression of DNAJB12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:27,828,216...27,846,428
Ensembl chr20:27,828,235...27,846,427
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
increases expression |
EXP |
Finasteride results in increased expression of DNAJC10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
increases expression |
EXP |
Finasteride results in increased expression of DNAJC12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
|
|
G |
Dnajc15 |
DnaJ heat shock protein family (Hsp40) member C15 |
increases expression |
EXP |
Finasteride results in increased expression of DNAJC15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
|
|
G |
Dnlz |
DNL-type zinc finger |
increases expression |
EXP |
Finasteride results in increased expression of DNLZ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:9,169,948...9,171,727
Ensembl chr 3:9,169,793...9,180,551
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
increases expression |
EXP |
Finasteride results in increased expression of DNPH1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
|
|
G |
Dph3 |
diphthamide biosynthesis 3 |
increases expression |
EXP |
Finasteride results in increased expression of DPH3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
|
|
G |
Dpy30 |
dpy-30 histone methyltransferase complex regulatory subunit |
increases expression |
EXP |
Finasteride results in increased expression of DPY30 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:21,120,947...21,141,720
Ensembl chr 6:21,120,947...21,141,432
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
increases expression |
EXP |
Finasteride results in increased expression of DPYSL2 protein |
CTD |
PMID:27750143 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Drosha |
drosha ribonuclease III |
increases expression |
EXP |
Finasteride results in increased expression of DROSHA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:61,864,886...61,976,688
Ensembl chr 2:61,864,970...61,976,688
|
|
G |
Dtymk |
deoxythymidylate kinase |
increases expression |
EXP |
Finasteride results in increased expression of DTYMK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
|
|
G |
Dus2 |
dihydrouridine synthase 2 |
increases expression |
EXP |
Finasteride results in increased expression of DUS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:33,906,517...33,954,922
Ensembl chr19:33,911,750...33,954,709
|
|
G |
Dusp11 |
dual specificity phosphatase 11 |
increases expression |
EXP |
Finasteride results in increased expression of DUSP11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
|
|
G |
Dusp22 |
dual specificity phosphatase 22 |
increases expression |
EXP |
Finasteride results in increased expression of DUSP22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:33,780,980...33,831,241
Ensembl chr17:33,780,981...33,831,321
|
|
G |
Dusp3 |
dual specificity phosphatase 3 |
increases expression |
EXP |
Finasteride results in increased expression of DUSP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
|
|
G |
Dut |
deoxyuridine triphosphatase |
increases expression |
EXP |
Finasteride results in increased expression of DUT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
increases expression |
EXP |
Finasteride results in increased expression of DYNLL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
|
|
G |
Dynll2 |
dynein light chain LC8-type 2 |
increases expression |
EXP |
Finasteride results in increased expression of DYNLL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:72,767,035...72,785,824
Ensembl chr10:72,767,035...72,785,805
|
|
G |
Eaf2 |
ELL associated factor 2 |
multiple interactions |
ISO |
Finasteride promotes the reaction [Testosterone results in increased expression of EAF2 mRNA] |
CTD |
PMID:20564326 |
|
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
|
|
G |
Ebag9 |
estrogen receptor binding site associated antigen 9 |
increases expression |
EXP |
Finasteride results in increased expression of EBAG9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:75,810,950...75,828,902
Ensembl chr 7:75,810,594...75,861,248
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
increases expression |
EXP |
Finasteride results in increased expression of ECI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Eci2 |
enoyl-CoA delta isomerase 2 |
increases expression |
EXP |
Finasteride results in increased expression of ECI2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
|
|
G |
Ecpas |
Ecm29 proteasome adaptor and scaffold |
increases expression |
EXP |
Finasteride results in increased expression of ECPAS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:73,601,745...73,714,026
Ensembl chr 5:73,604,533...73,713,860
|
|
G |
Ecsit |
ECSIT signaling integrator |
increases expression |
EXP |
Finasteride results in increased expression of ECSIT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:20,605,583...20,618,453
Ensembl chr 8:20,605,583...20,618,390
|
|
G |
Eefsec |
eukaryotic elongation factor, selenocysteine-tRNA-specific |
increases expression |
EXP |
Finasteride results in increased expression of EEFSEC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:120,719,616...120,915,779
Ensembl chr 4:120,707,133...120,915,779
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Testosterone results in increased expression of EGF protein] |
CTD |
PMID:27866977 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eif2b5 |
eukaryotic translation initiation factor 2B subunit epsilon |
increases expression |
EXP |
Finasteride results in increased expression of EIF2B5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:80,394,433...80,404,468
Ensembl chr11:80,394,433...80,404,419
|
|
G |
Eif2d |
eukaryotic translation initiation factor 2D |
increases expression |
EXP |
Finasteride results in increased expression of EIF2D mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:42,615,901...42,637,107
Ensembl chr13:42,615,911...42,639,719
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
increases expression |
EXP |
Finasteride results in increased expression of EIF4G1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
increases expression |
EXP |
Finasteride results in increased expression of EIF4G3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:150,197,410...150,418,862
Ensembl chr 5:150,195,226...150,418,363
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
increases expression |
EXP |
Finasteride results in increased expression of EIF5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
increases expression |
EXP |
Finasteride results in increased expression of EIF5B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Elac2 |
elaC ribonuclease Z 2 |
increases expression |
EXP |
Finasteride results in increased expression of ELAC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614
|
|
G |
Eloc |
elongin C |
increases expression |
EXP |
Finasteride results in increased expression of ELOC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:2,661,527...2,677,893
Ensembl chr 5:2,661,724...2,677,890
|
|
G |
Emc8 |
ER membrane protein complex subunit 8 |
increases expression |
EXP |
Finasteride results in increased expression of EMC8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:48,708,304...48,721,626
Ensembl chr19:48,582,574...48,721,543
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
increases expression |
EXP |
Finasteride results in increased expression of ENTPD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
Finasteride results in increased expression of EPHX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
increases expression |
EXP |
Finasteride results in increased expression of ERCC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ergic2 |
ERGIC and golgi 2 |
increases expression |
EXP |
Finasteride results in increased expression of ERGIC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:181,090,808...181,123,074
Ensembl chr 4:181,090,808...181,123,060
|
|
G |
Ermp1 |
endoplasmic reticulum metallopeptidase 1 |
increases expression |
EXP |
Finasteride results in increased expression of ERMP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:227,383,992...227,422,120
Ensembl chr 1:227,387,920...227,436,909
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of ERRFI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions affects expression |
EXP ISO |
Finasteride inhibits the reaction [Testosterone results in increased expression of ESR1 protein] Finasteride binds to and results in increased activity of ESR1 protein Finasteride affects the expression of ESR1 mRNA |
CTD |
PMID:27866977 PMID:30768126 PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Finasteride binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
increases expression |
EXP |
Finasteride results in increased expression of ETFDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Exoc3 |
exocyst complex component 3 |
increases expression |
EXP |
Finasteride results in increased expression of EXOC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045
|
|
G |
Exoc7 |
exocyst complex component 7 |
increases expression |
EXP |
Finasteride results in increased expression of EXOC7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:101,521,630...101,540,425
Ensembl chr10:101,520,927...101,540,561
|
|
G |
Exosc4 |
exosome component 4 |
increases expression |
EXP |
Finasteride results in increased expression of EXOSC4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
|
|
G |
Exosc5 |
exosome component 5 |
increases expression |
EXP |
Finasteride results in increased expression of EXOSC5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Exosc7 |
exosome component 7 |
increases expression |
EXP |
Finasteride results in increased expression of EXOSC7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:122,773,607...122,798,943
Ensembl chr 8:122,773,591...122,799,270
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
increases expression |
EXP |
Finasteride results in increased expression of FAM114A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fam136a |
family with sequence similarity 136, member A |
increases expression |
EXP |
Finasteride results in increased expression of FAM136A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:118,805,129...118,811,046
Ensembl chr 4:118,805,127...118,811,047
|
|
G |
Fam174c |
family with sequence similarity 174 member C |
increases expression |
EXP |
Finasteride results in increased expression of FAM174C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:9,531,995...9,533,705
|
|
G |
Fam210a |
family with sequence similarity 210, member A |
increases expression |
EXP |
Finasteride results in increased expression of FAM210A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:61,846,447...61,886,123
Ensembl chr18:61,852,907...61,886,171
|
|
G |
Fam219b |
family with sequence similarity 219, member B |
decreases expression |
EXP |
Finasteride results in decreased expression of FAM219B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:57,941,327...57,946,916
Ensembl chr 8:57,941,294...57,946,906
|
|
G |
Fam241b |
family with sequence similarity 241 member B |
increases expression |
EXP |
Finasteride results in increased expression of FAM241B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
|
|
G |
Fam32a |
family with sequence similarity 32, member A |
increases expression |
EXP |
Finasteride results in increased expression of FAM32A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:17,603,054...17,607,376
Ensembl chr16:17,603,946...17,607,398
|
|
G |
Fars2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
increases expression |
EXP |
Finasteride results in increased expression of FARS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:28,319,215...28,746,217
Ensembl chr17:28,319,280...28,746,337
|
|
G |
Fbxl4 |
F-box and leucine-rich repeat protein 4 |
increases expression |
EXP |
Finasteride results in increased expression of FBXL4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:35,955,801...36,029,446
Ensembl chr 5:35,955,812...36,029,443
|
|
G |
Fbxo31 |
F-box protein 31 |
increases expression |
EXP |
Finasteride results in increased expression of FBXO31 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:49,624,813...49,656,052
Ensembl chr19:49,627,686...49,656,010
|
|
G |
Fbxo6 |
F-box protein 6 |
increases expression |
EXP |
Finasteride results in increased expression of FBXO6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
|
|
G |
Fcf1 |
Fcf1 rRNA-processing protein |
increases expression |
EXP |
Finasteride results in increased expression of FCF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:104,617,780...104,629,643
Ensembl chr 6:104,617,770...104,629,643
|
|
G |
Fdx2 |
ferredoxin 2 |
increases expression |
EXP |
Finasteride results in increased expression of FDX2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:19,604,916...19,609,832
Ensembl chr 8:19,604,916...19,609,849
|
|
G |
Fech |
ferrochelatase |
increases expression |
EXP |
Finasteride results in increased expression of FECH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Testosterone results in increased expression of FGF2 protein] |
CTD |
PMID:27866977 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression |
EXP |
Finasteride results in increased expression of FKBP1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp3 |
FKBP prolyl isomerase 3 |
increases expression |
EXP |
Finasteride results in increased expression of FKBP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:83,113,885...83,125,500
Ensembl chr 6:83,113,786...83,127,011
|
|
G |
Fkbp4 |
FKBP prolyl isomerase 4 |
increases expression |
EXP |
Finasteride results in increased expression of FKBP4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
|
|
G |
Fli1 |
Fli-1 proto-oncogene, ETS transcription factor |
decreases expression |
EXP |
Finasteride results in decreased expression of FLI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:30,832,753...30,950,433
|
|
G |
Flnb |
filamin B |
increases expression |
EXP |
Finasteride results in increased expression of FLNB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
|
|
G |
Frrs1 |
ferric-chelate reductase 1 |
increases expression |
EXP |
Finasteride results in increased expression of FRRS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:204,820,898...204,881,487
Ensembl chr 2:204,823,025...204,895,540
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
EXP |
Finasteride results in increased expression of FTL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of FUBP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Fxn |
frataxin |
increases expression |
EXP |
Finasteride results in increased expression of FXN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
|
|
G |
Fxr1 |
FMR1 autosomal homolog 1 |
increases expression |
EXP |
Finasteride results in increased expression of FXR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:116,884,167...116,937,590
Ensembl chr 2:116,884,248...116,937,590
|
|
G |
Gaa |
alpha glucosidase |
increases expression |
EXP |
Finasteride results in increased expression of GAA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
|
|
G |
Gabarapl2 |
GABA type A receptor associated protein like 2 |
increases expression |
EXP |
Finasteride results in increased expression of GABARAPL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:39,910,572...39,921,408
Ensembl chr19:39,910,534...39,924,628 Ensembl chr 8:39,910,534...39,924,628
|
|
G |
Gabrd |
gamma-aminobutyric acid type A receptor subunit delta |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Progesterone affects the expression of GABRD mRNA]; Finasteride inhibits the reaction [Progesterone affects the expression of GABRD protein] |
CTD |
PMID:16879715 PMID:16914187 |
|
NCBI chr 5:165,958,508...165,970,407
Ensembl chr 5:165,958,484...165,970,411
|
|
G |
Gabrp |
gamma-aminobutyric acid type A receptor subunit pi |
decreases expression |
EXP |
Finasteride results in decreased expression of GABRP protein |
CTD |
PMID:27750143 |
|
NCBI chr10:18,143,031...18,169,595
Ensembl chr10:18,143,038...18,169,516
|
|
G |
Gadd45gip1 |
GADD45G interacting protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of GADD45GIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,320,662...23,323,211
Ensembl chr19:23,320,159...23,323,236
|
|
G |
Galk1 |
galactokinase 1 |
increases expression |
EXP |
Finasteride results in increased expression of GALK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
increases expression |
EXP |
Finasteride results in increased expression of GARS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gatad1 |
GATA zinc finger domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of GATAD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:30,507,530...30,519,107
Ensembl chr 4:30,507,538...30,519,107
|
|
G |
Gatad2a |
GATA zinc finger domain containing 2A |
increases expression |
EXP |
Finasteride results in increased expression of GATAD2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:19,429,578...19,520,320
Ensembl chr16:19,429,578...19,519,587
|
|
G |
Gatc |
glutamyl-tRNA amidotransferase subunit C |
increases expression |
EXP |
Finasteride results in increased expression of GATC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:41,270,096...41,278,067
Ensembl chr12:41,270,087...41,277,995
|
|
G |
Gba1 |
glucosylceramidase beta 1 |
increases expression |
EXP |
Finasteride results in increased expression of GBA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,609,437...174,615,457
Ensembl chr 2:174,609,403...174,618,263
|
|
G |
Get3 |
guided entry of tail-anchored proteins factor 3, ATPase |
increases expression |
EXP |
Finasteride results in increased expression of GET3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,130,109...23,138,196
Ensembl chr19:23,130,109...23,138,193
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Butyrates results in increased expression of GFAP mRNA]; Finasteride inhibits the reaction [Butyrates results in increased expression of GFAP protein]; Finasteride inhibits the reaction [Progesterone results in increased expression of GFAP mRNA]; Finasteride inhibits the reaction [trichostatin A results in increased expression of GFAP mRNA]; Finasteride inhibits the reaction [trichostatin A results in increased expression of GFAP protein]; Finasteride inhibits the reaction [Valproic Acid results in increased expression of GFAP mRNA]; Finasteride inhibits the reaction [Valproic Acid results in increased expression of GFAP protein] |
CTD |
PMID:19360904 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
increases expression |
EXP |
Finasteride results in increased expression of GFER mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
|
|
G |
Gfm1 |
G elongation factor, mitochondrial 1 |
increases expression |
EXP |
Finasteride results in increased expression of GFM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
|
|
G |
Gga2 |
golgi associated, gamma adaptin ear containing, ARF binding protein 2 |
increases expression |
EXP |
Finasteride results in increased expression of GGA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:176,552,046...176,585,332
Ensembl chr 1:176,552,046...176,585,361
|
|
G |
Ghitm |
growth hormone inducible transmembrane protein |
increases expression |
EXP |
Finasteride results in increased expression of GHITM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
|
|
G |
Gk |
glycerol kinase |
increases expression |
EXP |
Finasteride results in increased expression of GK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Gkap1 |
G kinase anchoring protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of GKAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:6,383,963...6,423,684
Ensembl chr17:6,383,963...6,423,679
|
|
G |
Glrx2 |
glutaredoxin 2 |
increases expression |
EXP |
Finasteride results in increased expression of GLRX2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:55,481,875...55,504,737
Ensembl chr13:55,482,694...55,492,831
|
|
G |
Glrx3 |
glutaredoxin 3 |
increases expression |
EXP |
Finasteride results in increased expression of GLRX3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
|
|
G |
Glyr1 |
glyoxylate reductase 1 homolog |
increases expression |
EXP |
Finasteride results in increased expression of GLYR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:10,532,036...10,567,639
Ensembl chr10:10,532,154...10,567,637
|
|
G |
Gna12 |
G protein subunit alpha 12 |
increases expression |
EXP |
Finasteride results in increased expression of GNA12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:13,805,580...13,886,255
Ensembl chr12:13,805,698...13,886,255
|
|
G |
Gnas |
GNAS complex locus |
increases expression |
EXP |
Finasteride results in increased expression of GNAS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gng12 |
G protein subunit gamma 12 |
increases expression |
EXP |
Finasteride results in increased expression of GNG12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:96,010,952...96,134,712
|
|
G |
Gnl3l |
G protein nucleolar 3 like |
increases expression |
EXP |
Finasteride results in increased expression of GNL3L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:19,961,277...19,994,454
Ensembl chr X:19,958,603...19,994,508
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
EXP |
Finasteride results in decreased expression of GNMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gnpat |
glyceronephosphate O-acyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of GNPAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361
|
|
G |
Golim4 |
golgi integral membrane protein 4 |
increases expression |
EXP |
Finasteride results in increased expression of GOLIM4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:160,640,837...160,733,475
Ensembl chr 2:160,640,938...160,733,253
|
|
G |
Golt1a |
golgi transport 1A |
increases expression |
EXP |
Finasteride results in increased expression of GOLT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:44,760,356...44,773,123
Ensembl chr13:44,760,380...44,773,122
|
|
G |
Gosr1 |
golgi SNAP receptor complex member 1 |
increases expression |
EXP |
Finasteride results in increased expression of GOSR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:61,570,499...61,607,287
Ensembl chr10:61,450,494...61,607,177 Ensembl chr10:61,450,494...61,607,177
|
|
G |
Gpx5 |
glutathione peroxidase 5 |
decreases expression |
EXP |
Finasteride results in decreased expression of GPX5 mRNA |
CTD |
PMID:18811921 |
|
NCBI chr17:43,436,126...43,443,074
Ensembl chr17:43,416,340...43,443,074
|
|
G |
Gramd2b |
GRAM domain containing 2B |
increases expression |
EXP |
Finasteride results in increased expression of GRAMD2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:49,884,014...49,981,955
Ensembl chr18:49,884,014...49,981,953
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
increases expression |
EXP |
Finasteride results in increased expression of GRB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of GRINA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
increases expression |
EXP |
Finasteride results in increased expression of GRK6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
EXP |
Finasteride results in increased expression of GSR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
EXP |
Finasteride results in increased expression of GSTA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
EXP |
Finasteride results in increased expression of GSTA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
EXP |
Finasteride results in increased expression of GSTM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
increases expression |
EXP |
Finasteride results in increased expression of GSTM4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gtf2b |
general transcription factor IIB |
increases expression |
EXP |
Finasteride results in increased expression of GTF2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
|
|
G |
Gtf2h1 |
general transcription factor IIH subunit 1 |
increases expression |
EXP |
Finasteride results in increased expression of GTF2H1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:97,321,417...97,349,455
Ensembl chr 1:97,321,394...97,349,455
|
|
G |
Gtpbp10 |
GTP binding protein 10 |
increases expression |
EXP |
Finasteride results in increased expression of GTPBP10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:28,476,857...28,494,375
Ensembl chr 4:28,476,857...28,494,375
|
|
G |
H2az1 |
H2A.Z variant histone 1 |
increases expression |
EXP |
Finasteride results in increased expression of H2AZ1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:226,355,668...226,357,984
Ensembl chr 2:226,355,708...226,358,485
|
|
G |
Hacd2 |
3-hydroxyacyl-CoA dehydratase 2 |
increases expression |
EXP |
Finasteride results in increased expression of HACD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:65,667,671...65,762,903
Ensembl chr11:65,670,281...65,762,889
|
|
G |
Hacd3 |
3-hydroxyacyl-CoA dehydratase 3 |
increases expression |
EXP |
Finasteride results in increased expression of HACD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
|
|
G |
Hace1 |
HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 |
increases expression |
EXP |
Finasteride results in increased expression of HACE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:49,035,312...49,151,103
Ensembl chr20:49,035,648...49,151,103
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
increases expression |
EXP |
Finasteride results in increased expression of HADHB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hat1 |
histone acetyltransferase 1 |
increases expression |
EXP |
Finasteride results in increased expression of HAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
|
|
G |
Hdac6 |
histone deacetylase 6 |
increases expression |
EXP |
Finasteride results in increased expression of HDAC6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
|
|
G |
Hdgf |
heparin binding growth factor |
increases expression |
EXP |
Finasteride results in increased expression of HDGF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:173,370,147...173,379,756
Ensembl chr 2:173,370,465...173,379,747
|
|
G |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
increases expression |
EXP |
Finasteride results in increased expression of HECTD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
|
|
G |
Helz2 |
helicase with zinc finger 2 |
decreases expression |
EXP |
Finasteride results in decreased expression of HELZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
|
|
G |
Hexb |
hexosaminidase subunit beta |
increases expression |
EXP |
Finasteride results in increased expression of HEXB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hibch |
3-hydroxyisobutyryl-CoA hydrolase |
increases expression |
EXP |
Finasteride results in increased expression of HIBCH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Testosterone results in increased expression of HIF1A protein] |
CTD |
PMID:27866977 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Higd1a |
HIG1 hypoxia inducible domain family, member 1A |
increases expression |
EXP |
Finasteride results in increased expression of HIGD1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:121,514,152...121,523,382
Ensembl chr 8:121,514,156...121,523,443
|
|
G |
Hikeshi |
heat shock protein nuclear import factor hikeshi |
increases expression |
EXP |
Finasteride results in increased expression of HIKESHI mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:143,825,399...143,849,361
Ensembl chr 1:143,825,923...143,849,363
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
increases expression |
EXP |
Finasteride results in increased expression of HMBS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
|
|
G |
Hmgb2 |
high mobility group box 2 |
increases expression |
EXP |
Finasteride results in increased expression of HMGB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgb3 |
high mobility group box 3 |
increases expression |
EXP |
Finasteride results in increased expression of HMGB3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292
|
|
G |
Hmgcl |
3-hydroxy-3-methylglutaryl-CoA lyase |
increases expression |
EXP |
Finasteride results in increased expression of HMGCL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:148,178,203...148,192,072
Ensembl chr 5:148,178,252...148,192,068
|
|
G |
Hmgn3 |
high mobility group nucleosomal binding domain 3 |
increases expression |
EXP |
Finasteride results in increased expression of HMGN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
|
|
G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 |
increases expression |
EXP |
Finasteride results in increased expression of HNRNPH2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:97,780,890...97,786,846
Ensembl chr X:97,780,785...97,787,041
|
|
G |
Hnrnpll |
heterogeneous nuclear ribonucleoprotein L-like |
increases expression |
EXP |
Finasteride results in increased expression of HNRNPLL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:14,969,953...15,000,574
Ensembl chr 6:14,970,057...14,999,745
|
|
G |
Hpf1 |
histone PARylation factor 1 |
increases expression |
EXP |
Finasteride results in increased expression of HPF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:29,203,749...29,219,651
Ensembl chr16:29,183,256...29,219,716
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
EXP |
Finasteride results in increased expression of HRAS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
increases expression |
EXP |
Finasteride results in increased expression of HSD17B4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
increases expression |
EXP |
Finasteride results in increased expression of HSD17B7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
increases expression |
EXP |
Finasteride results in increased expression of HSDL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
EXP |
Finasteride results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
increases expression |
EXP |
Finasteride results in increased expression of HSP90AB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
increases expression |
EXP |
Finasteride results in increased expression of HSPA4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
increases expression |
EXP |
Finasteride results in increased expression of HSPA9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
EXP |
Finasteride results in increased expression of HSPB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
Finasteride results in increased expression of HSPD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Hspe1 |
heat shock protein family E (Hsp10) member 1 |
increases expression |
EXP |
Finasteride results in increased expression of HSPE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
EXP |
Finasteride results in increased expression of HTATIP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Iars2 |
isoleucyl-tRNA synthetase 2, mitochondrial |
increases expression |
EXP |
Finasteride results in increased expression of IARS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:96,831,484...96,865,518
Ensembl chr13:96,831,484...96,865,501
|
|
G |
Iba57 |
iron-sulfur cluster assembly factor IBA57 |
increases expression |
EXP |
Finasteride results in increased expression of IBA57 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:43,942,017...43,950,807
Ensembl chr10:43,942,017...43,950,807
|
|
G |
Ide |
insulin degrading enzyme |
increases expression |
EXP |
Finasteride results in increased expression of IDE mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
decreases expression |
EXP |
Finasteride results in decreased expression of IFI27 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
decreases expression |
EXP |
Finasteride results in decreased expression of IFITM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifnar1 |
interferon alpha and beta receptor subunit 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of IFNAR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
|
|
G |
Iftap |
intraflagellar transport associated protein |
increases expression |
EXP |
Finasteride results in increased expression of IFTAP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
increases expression |
EXP |
Finasteride results in increased expression of IGF2R mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Igsf11 |
immunoglobulin superfamily, member 11 |
increases expression |
EXP |
Finasteride results in increased expression of IGSF11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:61,733,139...61,884,059
Ensembl chr11:61,733,144...61,868,348
|
|
G |
Ik |
IK cytokine |
increases expression |
EXP |
Finasteride results in increased expression of IK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:28,358,004...28,372,809
Ensembl chr18:28,357,977...28,378,832
|
|
G |
Il11ra1 |
interleukin 11 receptor subunit alpha 1 |
increases expression |
EXP |
Finasteride results in increased expression of IL11RA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:56,931,824...56,941,408
Ensembl chr 5:56,935,516...56,941,408
|
|
G |
Il1b |
interleukin 1 beta |
increases response to substance multiple interactions |
ISO |
Finasteride results in increased susceptibility to IL1B protein [Finasteride results in increased susceptibility to IL1B protein] which results in increased expression of CRH mRNA; [Finasteride results in increased susceptibility to IL1B protein] which results in increased secretion of Corticosterone; [Finasteride results in increased susceptibility to IL1B protein] which results in increased secretion of POMC protein |
CTD |
PMID:19458216 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Finasteride inhibits the reaction [testosterone enanthate results in increased expression of IL6 protein] |
CTD |
PMID:36015278 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Immt |
inner membrane mitochondrial protein |
increases expression |
EXP |
Finasteride results in increased expression of IMMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Ints4 |
integrator complex subunit 4 |
increases expression |
EXP |
Finasteride results in increased expression of INTS4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:151,790,062...151,853,827
Ensembl chr 1:151,786,553...151,853,827
|
|
G |
Ipmk |
inositol polyphosphate multikinase |
increases expression |
EXP |
Finasteride results in increased expression of IPMK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:17,216,988...17,251,675
Ensembl chr20:17,218,037...17,251,705
|
|
G |
Ipo4 |
importin 4 |
increases expression |
EXP |
Finasteride results in increased expression of IPO4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
increases expression |
EXP |
Finasteride results in increased expression of IRAK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
increases expression |
EXP |
Finasteride results in increased expression of IREB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
EXP |
Finasteride results in decreased expression of IRF7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Isca1 |
iron-sulfur cluster assembly 1 |
increases expression |
EXP |
Finasteride results in increased expression of ISCA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:4,905,291...4,917,955
Ensembl chr17:4,905,287...4,917,955
|
|
G |
Itgb1bp1 |
integrin subunit beta 1 binding protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of ITGB1BP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:40,820,693...40,836,074
Ensembl chr 6:40,821,339...40,836,037
|
|
G |
Itsn2 |
intersectin 2 |
increases expression |
EXP |
Finasteride results in increased expression of ITSN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:27,616,645...27,727,373
Ensembl chr 6:27,600,406...27,727,124
|
|
G |
Jkamp |
JNK1/MAPK8-associated membrane protein |
increases expression |
EXP |
Finasteride results in increased expression of JKAMP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:90,648,043...90,661,985
Ensembl chr 6:90,648,160...90,662,501
|
|
G |
Josd1 |
Josephin domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of JOSD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:111,230,318...111,244,241
Ensembl chr 7:111,230,318...111,244,652
|
|
G |
Katna1 |
katanin catalytic subunit A1 |
increases expression |
EXP |
Finasteride results in increased expression of KATNA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:2,202,501...2,244,132
Ensembl chr 1:2,202,490...2,244,131
|
|
G |
Kcnc3 |
potassium voltage-gated channel subfamily C member 3 |
decreases expression |
EXP |
Finasteride results in decreased expression of KCNC3 protein |
CTD |
PMID:27750143 |
|
NCBI chr 1:95,080,960...95,095,165
Ensembl chr 1:95,080,960...95,095,160
|
|
G |
Kcnh3 |
potassium voltage-gated channel subfamily H member 3 |
decreases expression |
EXP |
Finasteride results in decreased expression of KCNH3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:130,365,593...130,383,859
Ensembl chr 7:130,366,011...130,383,855
|
|
G |
Kctd5 |
potassium channel tetramerization domain containing 5 |
increases expression |
EXP |
Finasteride results in increased expression of KCTD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,079,216...13,105,197
Ensembl chr10:13,079,214...13,105,209
|
|
G |
Kctd9 |
potassium channel tetramerization domain containing 9 |
increases expression |
EXP |
Finasteride results in increased expression of KCTD9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:41,942,165...41,969,862
Ensembl chr15:41,942,381...41,969,862
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of KEAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kgd4 |
alpha-ketoglutarate dehydrogenase subunit 4 |
increases expression |
EXP |
Finasteride results in increased expression of KGD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:31,870,549...31,878,335
Ensembl chr 2:31,870,551...31,880,730
|
|
G |
Khsrp |
KH-type splicing regulatory protein |
increases expression |
EXP |
Finasteride results in increased expression of KHSRP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,862,555...1,872,403
Ensembl chr 9:1,862,899...1,872,451
|
|
G |
Kif21a |
kinesin family member 21A |
increases expression |
EXP |
Finasteride results in increased expression of KIF21A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:122,062,523...122,179,051
Ensembl chr 7:122,062,537...122,178,999
|
|
G |
Klhdc2 |
kelch domain containing 2 |
increases expression |
EXP |
Finasteride results in increased expression of KLHDC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:87,777,183...87,791,609
Ensembl chr 6:87,777,183...87,804,187
|
|
G |
Klhl22 |
kelch-like family member 22 |
increases expression |
EXP |
Finasteride results in increased expression of KLHL22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:83,190,891...83,231,746
Ensembl chr11:83,190,891...83,231,770
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
decreases expression |
ISO |
Finasteride results in decreased expression of KLK3 protein |
CTD |
PMID:11118046 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
increases expression |
EXP |
Finasteride results in increased expression of KPNA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Kpna3 |
karyopherin subunit alpha 3 |
increases expression |
EXP |
Finasteride results in increased expression of KPNA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:35,536,310...35,610,066
Ensembl chr15:35,536,316...35,610,419
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
increases expression |
EXP |
Finasteride results in increased expression of KPNB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
|
|
G |
Krt18 |
keratin 18 |
increases expression |
EXP |
Finasteride results in increased expression of KRT18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Kxd1 |
KxDL motif containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of KXD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,895,343...18,916,266
Ensembl chr16:18,900,616...18,920,807
|
|
G |
Lactb2 |
lactamase, beta 2 |
increases expression |
EXP |
Finasteride results in increased expression of LACTB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
|
|
G |
Lamtor4 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 |
increases expression |
EXP |
Finasteride results in increased expression of LAMTOR4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:17,258,656...17,262,478
Ensembl chr12:17,258,623...17,262,480
|
|
G |
Lamtor5 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
increases expression |
EXP |
Finasteride results in increased expression of LAMTOR5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:194,900,038...194,905,394
Ensembl chr 2:194,900,038...194,905,395
|
|
G |
Larp1b |
La ribonucleoprotein 1B |
increases expression |
EXP |
Finasteride results in increased expression of LARP1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
|
|
G |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
increases expression |
EXP |
Finasteride results in increased expression of LCMT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:177,904,119...177,960,111
Ensembl chr 1:177,904,139...177,960,112
|
|
G |
Letm1 |
leucine zipper and EF-hand containing transmembrane protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of LETM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:76,942,647...76,982,220
Ensembl chr14:76,942,729...76,984,904
|
|
G |
Lgals8 |
galectin 8 |
increases expression |
EXP |
Finasteride results in increased expression of LGALS8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
|
|
G |
Lin37 |
lin-37 DREAM MuvB core complex component |
increases expression |
EXP |
Finasteride results in increased expression of LIN37 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:85,809,065...85,813,235
Ensembl chr 1:85,809,074...85,812,991
|
|
G |
Lipe |
lipase E, hormone sensitive type |
decreases expression |
EXP |
Finasteride results in decreased expression of LIPE mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
|
|
G |
Litaf |
lipopolysaccharide-induced TNF factor |
increases expression |
EXP |
Finasteride results in increased expression of LITAF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
|
|
G |
Lmf1 |
lipase maturation factor 1 |
increases expression |
EXP |
Finasteride results in increased expression of LMF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:14,597,726...14,684,071
Ensembl chr10:14,597,594...14,684,119
|
|
G |
Lmf2 |
lipase maturation factor 2 |
increases expression |
EXP |
Finasteride results in increased expression of LMF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:120,418,343...120,422,825
Ensembl chr 7:120,418,345...120,422,823
|
|
G |
Lmna |
lamin A/C |
increases expression |
EXP |
Finasteride results in increased expression of LMNA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
increases expression |
EXP |
Finasteride results in increased expression of LONP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
|
|
G |
Lrpprc |
leucine-rich pentatricopeptide repeat containing |
increases expression |
EXP |
Finasteride results in increased expression of LRPPRC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:9,859,816...9,942,294
Ensembl chr 6:9,859,867...9,942,293
|
|
G |
Lsm10 |
LSM10, U7 small nuclear RNA associated |
increases expression |
EXP |
Finasteride results in increased expression of LSM10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:138,365,983...138,375,856
Ensembl chr 5:138,373,119...138,377,505
|
|
G |
Lsm12 |
LSM12 homolog |
increases expression |
EXP |
Finasteride results in increased expression of LSM12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:87,118,334...87,140,395
Ensembl chr10:87,118,416...87,140,396
|
|
G |
Lsm2 |
LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
EXP |
Finasteride results in increased expression of LSM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:3,843,467...3,847,217
Ensembl chr20:3,843,466...3,847,266
|
|
G |
Lsm4 |
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
EXP |
Finasteride results in increased expression of LSM4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
|
|
G |
Lsm6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
EXP |
Finasteride results in increased expression of LSM6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
|
|
G |
Macroh2a1 |
macroH2A.1 histone |
increases expression |
EXP |
Finasteride results in increased expression of MACROH2A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:8,479,331...8,542,071
Ensembl chr17:8,479,372...8,542,072
|
|
G |
Mad2l2 |
mitotic arrest deficient 2 like 2 |
increases expression |
EXP |
Finasteride results in increased expression of MAD2L2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:158,563,545...158,576,698
Ensembl chr 5:158,563,567...158,576,693
|
|
G |
Magoh |
mago homolog, exon junction complex subunit |
increases expression |
EXP |
Finasteride results in increased expression of MAGOH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:122,639,268...122,646,650
Ensembl chr 5:122,639,308...122,646,617
|
|
G |
Manbal |
mannosidase beta like |
increases expression |
EXP |
Finasteride results in increased expression of MANBAL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:146,035,082...146,064,676
Ensembl chr 3:146,035,066...146,064,676
|
|
G |
Maoa |
monoamine oxidase A |
increases expression |
EXP |
Finasteride results in increased expression of MAOA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
EXP |
Finasteride results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
increases expression |
EXP |
Finasteride results in increased expression of MAP2K2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases expression |
EXP |
Finasteride results in increased expression of MAPK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapkap1 |
MAPK associated protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of MAPKAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:17,715,813...17,918,387
Ensembl chr 3:17,715,834...17,918,384
|
|
G |
Mark3 |
microtubule affinity regulating kinase 3 |
increases expression |
EXP |
Finasteride results in increased expression of MARK3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647
|
|
G |
Mbd2 |
methyl-CpG binding domain protein 2 |
increases expression |
EXP |
Finasteride results in increased expression of MBD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
|
|
G |
Mbd3 |
methyl-CpG binding domain protein 3 |
increases expression |
EXP |
Finasteride results in increased expression of MBD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
|
|
G |
Mcoln1 |
mucolipin TRP cation channel 1 |
increases expression |
EXP |
Finasteride results in increased expression of MCOLN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:1,560,341...1,574,252
Ensembl chr12:1,560,359...1,574,252
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
EXP |
Finasteride results in increased expression of ME1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med10 |
mediator complex subunit 10 |
increases expression |
EXP |
Finasteride results in increased expression of MED10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:33,470,064...33,481,698
Ensembl chr 1:33,470,066...33,475,767
|
|
G |
Med21 |
mediator complex subunit 21 |
increases expression |
EXP |
Finasteride results in increased expression of MED21 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
|
|
G |
Med28 |
mediator complex subunit 28 |
increases expression |
EXP |
Finasteride results in increased expression of MED28 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:65,594,785...65,603,583
Ensembl chr14:65,594,647...65,603,583
|
|
G |
Med29 |
mediator complex subunit 29 |
increases expression |
EXP |
Finasteride results in increased expression of MED29 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365
|
|
G |
Med31 |
mediator complex subunit 31 |
increases expression |
EXP |
Finasteride results in increased expression of MED31 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326
|
|
G |
Med4 |
mediator complex subunit 4 |
increases expression |
EXP |
Finasteride results in increased expression of MED4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:48,696,542...48,706,818
Ensembl chr15:48,696,511...48,706,820
|
|
G |
Med6 |
mediator complex subunit 6 |
increases expression |
EXP |
Finasteride results in increased expression of MED6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:101,270,410...101,283,929
Ensembl chr 6:101,270,410...101,283,876
|
|
G |
Mesd |
mesoderm development LRP chaperone |
increases expression |
EXP |
Finasteride results in increased expression of MESD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:137,866,707...137,879,999
Ensembl chr 1:137,874,242...137,879,999
|
|
G |
Mettl23 |
methyltransferase 23, arginine |
increases expression |
EXP |
Finasteride results in increased expression of METTL23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:102,047,090...102,053,379
Ensembl chr10:102,047,314...102,051,977
|
|
G |
Mettl5 |
methyltransferase 5, N6-adenosine |
increases expression |
EXP |
Finasteride results in increased expression of METTL5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:54,625,790...54,638,066
Ensembl chr 3:54,625,793...54,638,039
|
|
G |
Mfap3 |
microfibril associated protein 3 |
increases expression |
EXP |
Finasteride results in increased expression of MFAP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:41,696,788...41,711,490
Ensembl chr10:41,696,771...41,710,406
|
|
G |
Mff |
mitochondrial fission factor |
increases expression |
EXP |
Finasteride results in increased expression of MFF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
|
|
G |
Mfn2 |
mitofusin 2 |
increases expression |
EXP |
Finasteride results in increased expression of MFN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mfsd4b2l1 |
major facilitator superfamily domain containing 4B2 like 1 |
increases expression |
EXP |
Finasteride results in increased expression of MFSD4B2L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:43,436,857...43,450,064
Ensembl chr20:43,436,857...43,450,064
|
|
G |
Mfsd5 |
major facilitator superfamily domain containing 5 |
increases expression |
EXP |
Finasteride results in increased expression of MFSD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:133,409,096...133,411,377
Ensembl chr 7:133,402,537...133,411,396
|
|
G |
Mgll |
monoglyceride lipase |
increases expression |
EXP |
Finasteride results in increased expression of MGLL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of MGMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
increases expression |
EXP |
Finasteride results in increased expression of MGST2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Micu1 |
mitochondrial calcium uptake 1 |
increases expression |
EXP |
Finasteride results in increased expression of MICU1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:27,668,681...27,816,322
Ensembl chr20:27,668,747...27,814,964
|
|
G |
Micu2 |
mitochondrial calcium uptake 2 |
increases expression |
EXP |
Finasteride results in increased expression of MICU2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:32,064,872...32,146,874
Ensembl chr15:32,064,875...32,147,094
|
|
G |
Mif |
macrophage migration inhibitory factor |
increases expression |
EXP |
Finasteride results in increased expression of MIF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Miox |
myo-inositol oxygenase |
increases expression |
EXP |
Finasteride results in increased expression of MIOX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537
|
|
G |
Mipep |
mitochondrial intermediate peptidase |
increases expression |
EXP |
Finasteride results in increased expression of MIPEP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:34,926,198...35,051,722
Ensembl chr15:34,926,207...35,051,727
|
|
G |
Mix23 |
mitochondrial matrix import factor 23 |
increases expression |
EXP |
Finasteride results in increased expression of MIX23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:64,660,711...64,681,000
Ensembl chr11:64,660,711...64,681,000
|
|
G |
Mlec |
malectin |
increases expression |
EXP |
Finasteride results in increased expression of MLEC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708
|
|
G |
Mllt6 |
MLLT6, PHD finger containing |
decreases expression |
EXP |
Finasteride results in decreased expression of MLLT6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:82,657,258...82,678,899
Ensembl chr10:82,656,872...82,676,073
|
|
G |
Mlycd |
malonyl-CoA decarboxylase |
increases expression |
EXP |
Finasteride results in increased expression of MLYCD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
increases expression |
EXP |
Finasteride results in increased expression of MMP14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mocs1 |
molybdenum cofactor synthesis 1 |
increases expression |
EXP |
Finasteride results in increased expression of MOCS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:11,547,533...11,573,935
Ensembl chr 9:11,547,531...11,567,790
|
|
G |
Mogs |
mannosyl-oligosaccharide glucosidase |
increases expression |
EXP |
Finasteride results in increased expression of MOGS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,621,623...115,625,026
Ensembl chr 4:115,621,623...115,625,032
|
|
G |
Mospd1 |
motile sperm domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of MOSPD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:133,100,200...133,127,960
Ensembl chr X:133,100,422...133,127,908 Ensembl chr 1:133,100,422...133,127,908
|
|
G |
Mospd2 |
motile sperm domain containing 2 |
increases expression |
EXP |
Finasteride results in increased expression of MOSPD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:29,420,485...29,472,099
Ensembl chr X:29,420,586...29,462,398
|
|
G |
Mpp1 |
MAGUK p55 scaffold protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of MPP1 mRNA |
CTD |
PMID:24136188 |
|
|
|
G |
Mro |
maestro |
increases expression |
EXP |
Finasteride results in increased expression of MRO mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:67,450,186...67,467,593
Ensembl chr18:67,450,595...67,467,044
|
|
G |
Mrpl1 |
mitochondrial ribosomal protein L1 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,300,522...13,359,721
|
|
G |
mrpl11 |
mitochondrial ribosomal protein L11 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:202,264,419...202,267,288
Ensembl chr 1:202,264,471...202,267,756
|
|
G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
|
|
G |
Mrpl13 |
mitochondrial ribosomal protein L13 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:86,951,541...86,973,147
Ensembl chr 7:86,951,541...86,973,577
|
|
G |
Mrpl14 |
mitochondrial ribosomal protein L14 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:15,302,840...15,315,195
Ensembl chr 9:15,302,427...15,315,267
|
|
G |
Mrpl17 |
mitochondrial ribosomal protein L17 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL17 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:160,162,181...160,163,870
Ensembl chr 1:160,158,807...160,163,815
|
|
G |
Mrpl19 |
mitochondrial ribosomal protein L19 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL19 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:114,521,824...114,526,053
Ensembl chr 4:114,521,824...114,526,053
|
|
G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492
|
|
G |
Mrpl22 |
mitochondrial ribosomal protein L22 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:42,345,446...42,355,779
Ensembl chr10:42,342,776...42,355,779
|
|
G |
Mrpl23 |
mitochondrial ribosomal protein L23 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:197,687,452...197,695,222
Ensembl chr 1:197,687,347...197,695,222
|
|
G |
mrpl24 |
mitochondrial ribosomal protein L24 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:173,383,062...173,389,249
Ensembl chr 2:173,383,224...173,389,248
|
|
G |
Mrpl30 |
mitochondrial ribosomal protein L30 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL30 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:40,125,352...40,136,189
Ensembl chr 9:40,125,430...40,137,257
|
|
G |
Mrpl32 |
mitochondrial ribosomal protein L32 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL32 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:50,565,133...50,568,000
Ensembl chr17:50,565,055...50,568,010
|
|
G |
Mrpl35 |
mitochondrial ribosomal protein L35 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL35 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:103,865,812...103,876,687
Ensembl chr 4:103,865,812...103,880,887
|
|
G |
Mrpl37 |
mitochondrial ribosomal protein L37 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL37 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:121,827,892...121,846,187
Ensembl chr 5:121,829,111...121,846,176
|
|
G |
Mrpl38 |
mitochondrial ribosomal protein L38 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL38 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:101,365,353...101,372,159
Ensembl chr10:101,365,353...101,372,171
|
|
G |
Mrpl39 |
mitochondrial ribosomal protein L39 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL39 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:23,779,655...23,795,146
Ensembl chr11:23,779,662...23,795,125
|
|
G |
Mrpl42 |
mitochondrial ribosomal protein L42 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL42 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:30,117,977...30,141,757
Ensembl chr 7:30,117,977...30,141,639
|
|
G |
Mrpl45 |
mitochondrial ribosomal protein L45 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL45 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:82,308,650...82,320,474
Ensembl chr10:82,308,427...82,320,474
|
|
G |
Mrpl46 |
mitochondrial ribosomal protein L46 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL46 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:132,698,872...132,707,639
Ensembl chr 1:132,698,601...132,707,628
|
|
G |
Mrpl48 |
mitochondrial ribosomal protein L48 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL48 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:154,896,663...154,939,285
Ensembl chr 1:154,896,663...154,939,281
|
|
G |
Mrpl49 |
mitochondrial ribosomal protein L49 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL49 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:203,346,068...203,350,040
Ensembl chr 1:203,332,481...203,350,049
|
|
G |
Mrpl50 |
mitochondrial ribosomal protein L50 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL50 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:63,867,437...63,872,591
|
|
G |
Mrpl53 |
mitochondrial ribosomal protein L53 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL53 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,615,329...115,616,219
|
|
G |
Mrpl54 |
mitochondrial ribosomal protein L54 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL54 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,452,801...8,455,321
Ensembl chr 7:8,452,716...8,455,321
|
|
G |
Mrpl55 |
mitochondrial ribosomal protein L55 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL55 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:43,988,676...43,991,841
Ensembl chr10:43,988,683...43,991,841
|
|
G |
Mrpl58 |
mitochondrial ribosomal protein L58 |
increases expression |
EXP |
Finasteride results in increased expression of MRPL58 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:100,646,374...100,652,871
Ensembl chr10:100,646,216...100,652,871
|
|
G |
Mrps12 |
mitochondrial ribosomal protein S12 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
|
|
G |
Mrps14 |
mitochondrial ribosomal protein S14 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:72,429,168...72,434,915
Ensembl chr13:72,408,558...72,434,915
|
|
G |
Mrps15 |
mitochondrial ribosomal protein S15 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:138,321,610...138,332,205
Ensembl chr 5:138,321,593...138,332,205
|
|
G |
Mrps18b |
mitochondrial ribosomal protein S18B |
increases expression |
EXP |
Finasteride results in increased expression of MRPS18B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
|
|
G |
Mrps18c |
mitochondrial ribosomal protein S18C |
increases expression |
EXP |
Finasteride results in increased expression of MRPS18C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:8,812,301...8,818,538
Ensembl chr14:8,791,330...8,818,516
|
|
G |
Mrps22 |
mitochondrial ribosomal protein S22 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:99,184,110...99,197,278
Ensembl chr 8:99,184,109...99,197,291
|
|
G |
Mrps24 |
mitochondrial ribosomal protein S24 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:80,584,671...80,588,801
Ensembl chr14:80,584,673...80,588,871
|
|
G |
Mrps30 |
mitochondrial ribosomal protein S30 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS30 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:50,456,253...50,463,128
Ensembl chr 2:50,456,255...50,463,105
|
|
G |
Mrps31 |
mitochondrial ribosomal protein S31 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS31 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:69,601,349...69,621,609
Ensembl chr16:69,601,349...69,630,654
|
|
G |
Mrps33 |
mitochondrial ribosomal protein S33 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS33 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:68,596,729...68,605,547
Ensembl chr 4:68,596,729...68,605,428
|
|
G |
Mrps7 |
mitochondrial ribosomal protein S7 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:100,843,691...100,846,838
Ensembl chr10:100,843,356...100,847,129
|
|
G |
Mrps9 |
mitochondrial ribosomal protein S9 |
increases expression |
EXP |
Finasteride results in increased expression of MRPS9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:45,113,554...45,172,375
Ensembl chr 9:45,113,554...45,172,375
|
|
G |
Msrb2 |
methionine sulfoxide reductase B2 |
increases expression |
EXP |
Finasteride results in increased expression of MSRB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
|
|
G |
Mta3 |
metastasis associated 1 family, member 3 |
increases expression |
EXP |
Finasteride results in increased expression of MTA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:10,867,028...10,987,221
Ensembl chr 6:10,867,011...10,986,883
|
|
G |
Mterf4 |
mitochondrial transcription termination factor 4 |
increases expression |
EXP |
Finasteride results in increased expression of MTERF4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:93,834,162...93,838,838
Ensembl chr 9:93,834,144...93,838,864
|
|
G |
Mtfmt |
mitochondrial methionyl-tRNA formyltransferase |
increases expression |
EXP |
Finasteride results in increased expression of MTFMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:65,953,787...65,971,841
Ensembl chr 8:65,953,767...65,971,841
|
|
G |
Mthfs |
methenyltetrahydrofolate synthetase |
increases expression |
EXP |
Finasteride results in increased expression of MTHFS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:89,729,498...89,801,998
Ensembl chr 8:89,729,508...89,799,089
|
|
G |
Mtif2 |
mitochondrial translational initiation factor 2 |
increases expression |
EXP |
Finasteride results in increased expression of MTIF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:103,265,808...103,285,733
Ensembl chr14:103,270,039...103,285,728
|
|
G |
Mtpap |
mitochondrial poly(A) polymerase |
increases expression |
EXP |
Finasteride results in increased expression of MTPAP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:53,320,739...53,341,500
Ensembl chr17:53,320,741...53,341,538
|
|
G |
Mtpn |
myotrophin |
increases expression |
EXP |
Finasteride results in increased expression of MTPN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:64,159,273...64,186,686
Ensembl chr 4:64,157,641...64,186,724
|
|
G |
Mug1 |
murinoglobulin 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of MUG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:155,076,270...155,130,051
Ensembl chr 4:155,076,312...155,130,051
|
|
G |
Mzf1 |
myeloid zinc finger 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of MZF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:73,670,522...73,682,885
Ensembl chr 1:73,670,541...73,681,635
|
|
G |
Naa20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
increases expression |
EXP |
Finasteride results in increased expression of NAA20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:133,322,036...133,336,843
Ensembl chr 3:133,322,064...133,337,009
|
|
G |
Naa35 |
N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
increases expression |
EXP |
Finasteride results in increased expression of NAA35 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:5,034,360...5,086,456
Ensembl chr17:5,034,356...5,086,386
|
|
G |
Naa38 |
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
increases expression |
EXP |
Finasteride results in increased expression of NAA38 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:54,117,754...54,118,913
Ensembl chr10:54,117,163...54,119,494
|
|
G |
Nadsyn1 |
NAD synthetase 1 |
increases expression |
EXP |
Finasteride results in increased expression of NADSYN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:198,981,559...199,009,853
Ensembl chr 1:198,981,604...199,009,869
|
|
G |
Nae1 |
NEDD8 activating enzyme E1 subunit 1 |
increases expression |
EXP |
Finasteride results in increased expression of NAE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:446,015...472,145
Ensembl chr19:446,000...472,371
|
|
G |
Nagk |
N-acetylglucosamine kinase |
increases expression |
EXP |
Finasteride results in increased expression of NAGK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:116,281,179...116,293,870
Ensembl chr 4:116,281,328...116,313,137
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
decreases expression |
EXP |
Finasteride results in decreased expression of NAMPT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
increases expression |
EXP |
Finasteride results in increased expression of NAP1L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
|
|
G |
Nbn |
nibrin |
increases expression |
EXP |
Finasteride results in increased expression of NBN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
increases expression |
EXP |
Finasteride results in increased expression of NCOR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of NDRG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
increases expression |
EXP |
Finasteride results in increased expression of NDUFA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598
|
|
G |
Ndufab1 |
NADH:ubiquinone oxidoreductase subunit AB1 |
increases expression |
EXP |
Finasteride results in increased expression of NDUFAB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:176,644,696...176,658,131
Ensembl chr 1:176,644,703...176,658,099
|
|
G |
Ndufaf3 |
NADH:ubiquinone oxidoreductase complex assembly factor 3 |
increases expression |
EXP |
Finasteride results in increased expression of NDUFAF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:109,261,362...109,263,194
Ensembl chr 8:109,261,363...109,263,194
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
increases expression |
EXP |
Finasteride results in increased expression of NDUFS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufv3 |
NADH:ubiquinone oxidoreductase subunit V3 |
increases expression |
EXP |
Finasteride results in increased expression of NDUFV3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:9,612,462...9,621,622
Ensembl chr20:9,612,431...9,623,074 Ensembl chr13:9,612,431...9,623,074
|
|
G |
Nek7 |
NIMA-related kinase 7 |
increases expression |
EXP |
Finasteride results in increased expression of NEK7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:50,022,212...50,149,374
Ensembl chr13:50,022,218...50,149,296
|
|
G |
Nfe2l1 |
NFE2 like bZIP transcription factor 1 |
increases expression |
EXP |
Finasteride results in increased expression of NFE2L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
|
|
G |
Nfic |
nuclear factor I/C |
increases expression |
EXP |
Finasteride results in increased expression of NFIC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936
|
|
G |
Nfkbib |
NFKB inhibitor beta |
increases expression |
EXP |
Finasteride results in increased expression of NFKBIB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nfu1 |
NFU1 iron-sulfur cluster scaffold |
increases expression |
EXP |
Finasteride results in increased expression of NFU1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:119,458,981...119,480,162
Ensembl chr 4:119,459,061...119,480,373
|
|
G |
Nfx1 |
nuclear transcription factor, X-box binding 1 |
increases expression |
EXP |
Finasteride results in increased expression of NFX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:56,104,945...56,162,912
Ensembl chr 5:56,105,234...56,162,912
|
|
G |
Nhlrc3 |
NHL repeat containing 3 |
increases expression |
EXP |
Finasteride results in increased expression of NHLRC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:137,527,843...137,542,258
Ensembl chr 2:137,530,012...137,534,879 Ensembl chr 2:137,530,012...137,534,879
|
|
G |
Nhp2 |
NHP2 ribonucleoprotein |
increases expression |
EXP |
Finasteride results in increased expression of NHP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545
|
|
G |
Nicn1 |
nicolin 1, tubulin polyglutamylase complex subunit |
increases expression |
EXP |
Finasteride results in increased expression of NICN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,976,393...108,981,620
Ensembl chr 8:108,976,464...108,981,067
|
|
G |
Nim1k |
NIM1 serine/threonine protein kinase |
increases expression |
EXP |
Finasteride results in increased expression of NIM1K mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:51,670,764...51,714,782
Ensembl chr 2:51,670,772...51,714,762
|
|
G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
increases expression |
EXP |
Finasteride results in increased expression of NME1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408
|
|
G |
Nmt1 |
N-myristoyltransferase 1 |
increases expression |
EXP |
Finasteride results in increased expression of NMT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:87,988,826...88,025,405
Ensembl chr10:87,988,826...88,022,648
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Finasteride inhibits the reaction [Testosterone results in increased expression of NOS2 protein] |
CTD |
PMID:27687055 PMID:27866977 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Npepl1 |
aminopeptidase-like 1 |
increases expression |
EXP |
Finasteride results in increased expression of NPEPL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:162,893,932...162,906,491
Ensembl chr 3:162,893,943...162,906,492
|
|
G |
Nphp1 |
nephrocystin 1 |
increases expression |
EXP |
Finasteride results in increased expression of NPHP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:114,960,650...115,016,234
Ensembl chr 3:114,960,650...115,016,234
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
Finasteride results in increased expression of NQO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
increases expression |
EXP |
Finasteride results in increased expression of NR1H2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression |
EXP |
Finasteride results in increased expression of NR1H3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
Finasteride results in increased activity of NR1I2 protein Finasteride binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21068194 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
increases expression |
EXP |
Finasteride results in increased expression of NR2F6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,046,012...18,053,914
Ensembl chr16:18,046,013...18,053,459
|
|
G |
Nsfl1c |
NSFL1 cofactor |
increases expression |
EXP |
Finasteride results in increased expression of NSFL1C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:139,978,306...140,002,876
Ensembl chr 3:139,978,301...140,002,870
|
|
G |
Nsmce1 |
NSE1 homolog, SMC5-SMC6 complex component |
increases expression |
EXP |
Finasteride results in increased expression of NSMCE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:180,030,355...180,058,541
Ensembl chr 1:180,030,160...180,058,417
|
|
G |
Nsmce2 |
NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase |
increases expression |
EXP |
Finasteride results in increased expression of NSMCE2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:90,936,112...91,173,435
Ensembl chr 7:90,936,112...91,164,899
|
|
G |
Nsmf |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
decreases expression |
EXP |
Finasteride results in decreased expression of NSMF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:7,861,846...7,870,615
Ensembl chr 3:7,861,872...7,870,614
|
|
G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
increases expression |
EXP |
Finasteride results in increased expression of NUCKS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:43,345,091...43,374,316
Ensembl chr13:43,345,115...43,370,229
|
|
G |
Nudc |
nuclear distribution C, dynein complex regulator |
increases expression |
EXP |
Finasteride results in increased expression of NUDC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:145,758,006...145,771,390
Ensembl chr 5:145,758,002...145,771,425
|
|
G |
Nudt16l1 |
nudix hydrolase 16 like 1 |
increases expression |
EXP |
Finasteride results in increased expression of NUDT16L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:10,636,174...10,638,090
Ensembl chr10:10,636,174...10,688,370
|
|
G |
Nudt18 |
nudix hydrolase 18 |
increases expression |
EXP |
Finasteride results in increased expression of NUDT18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:45,650,597...45,653,985
Ensembl chr15:45,650,664...45,653,963
|
|
G |
Nudt3 |
nudix hydrolase 3 |
increases expression |
EXP |
Finasteride results in increased expression of NUDT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:5,634,345...5,686,950
Ensembl chr20:5,634,349...5,686,874
|
|
G |
Nudt7 |
nudix hydrolase 7 |
increases expression |
EXP |
Finasteride results in increased expression of NUDT7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081
|
|
G |
Numb |
NUMB, endocytic adaptor protein |
increases expression |
EXP |
Finasteride results in increased expression of NUMB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:103,431,400...103,553,422
Ensembl chr 6:103,431,400...103,553,354
|
|
G |
Nup35 |
nucleoporin 35 |
increases expression |
EXP |
Finasteride results in increased expression of NUP35 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:65,555,203...65,594,488
Ensembl chr 3:65,558,968...65,585,130
|
|
G |
Nup37 |
nucleoporin 37 |
increases expression |
EXP |
Finasteride results in increased expression of NUP37 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:22,556,544...22,609,622
Ensembl chr 7:22,573,764...22,609,616
|
|
G |
Nupr2 |
nuclear protein 2, transcriptional regulator |
increases expression |
EXP |
Finasteride results in increased expression of NUPR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:26,800,123...26,803,228
Ensembl chr12:26,799,800...26,803,304
|
|
G |
Nus1 |
NUS1 dehydrodolichyl diphosphate synthase subunit |
increases expression |
EXP |
Finasteride results in increased expression of NUS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:31,811,817...31,838,562
Ensembl chr20:31,811,817...31,838,561
|
|
G |
Nutf2 |
nuclear transport factor 2 |
increases expression |
EXP |
Finasteride results in increased expression of NUTF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:33,752,319...33,773,595
Ensembl chr19:33,752,291...33,773,591
|
|
G |
Ocel1 |
occludin/ELL domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of OCEL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,042,037...18,045,080
Ensembl chr16:18,043,309...18,045,078
|
|
G |
Oplah |
5-oxoprolinase (ATP-hydrolysing) |
increases expression |
EXP |
Finasteride results in increased expression of OPLAH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297
|
|
G |
Optn |
optineurin |
increases expression |
EXP |
Finasteride results in increased expression of OPTN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
|
|
G |
Orc4 |
origin recognition complex, subunit 4 |
increases expression |
EXP |
Finasteride results in increased expression of ORC4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824
|
|
G |
Orc5 |
origin recognition complex, subunit 5 |
increases expression |
EXP |
Finasteride results in increased expression of ORC5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:12,548,007...12,612,611
Ensembl chr 4:12,548,007...12,612,568
|
|
G |
Osbpl9 |
oxysterol binding protein-like 9 |
increases expression |
EXP |
Finasteride results in increased expression of OSBPL9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:123,819,106...123,962,213
Ensembl chr 5:123,819,104...123,962,196
|
|
G |
Ostm1 |
osteoclastogenesis associated transmembrane protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of OSTM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:46,071,657...46,187,049
Ensembl chr20:46,153,075...46,187,023
|
|
G |
Oxsm |
3-oxoacyl-ACP synthase, mitochondrial |
increases expression |
EXP |
Finasteride results in increased expression of OXSM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:9,210,443...9,215,852
Ensembl chr15:9,210,547...9,214,558
|
|
G |
Pa2g4 |
proliferation-associated 2G4 |
increases expression |
EXP |
Finasteride results in increased expression of PA2G4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331
|
|
G |
Pabpn1 |
poly(A) binding protein, nuclear 1 |
increases expression |
EXP |
Finasteride results in increased expression of PABPN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:28,368,100...28,372,712
Ensembl chr15:28,368,100...28,372,703
|
|
G |
Pacsin3 |
protein kinase C and casein kinase substrate in neurons 3 |
increases expression |
EXP |
Finasteride results in increased expression of PACSIN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:77,227,187...77,235,820
Ensembl chr 3:77,222,710...77,235,811
|
|
G |
Padi2 |
peptidyl arginine deiminase 2 |
affects expression |
EXP |
Finasteride affects the expression of PADI2 mRNA |
CTD |
PMID:30768126 |
|
NCBI chr 5:153,209,053...153,251,632
Ensembl chr 5:153,209,053...153,251,632
|
|
G |
Paics |
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase |
increases expression |
EXP |
Finasteride results in increased expression of PAICS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:31,199,086...31,232,731
Ensembl chr14:31,173,541...31,232,635
|
|
G |
Pak6 |
p21 (RAC1) activated kinase 6 |
decreases expression |
EXP |
Finasteride results in decreased expression of PAK6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:105,638,248...105,674,399
Ensembl chr 3:105,638,653...105,672,975
|
|
G |
Pank1 |
pantothenate kinase 1 |
increases expression |
EXP |
Finasteride results in increased expression of PANK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
|
|
G |
Papola |
poly (A) polymerase alpha |
increases expression |
EXP |
Finasteride results in increased expression of PAPOLA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:124,682,015...124,734,706
Ensembl chr 6:124,682,105...124,734,468
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
decreases expression |
EXP |
Finasteride results in decreased expression of PARP14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Patj |
PATJ, crumbs cell polarity complex component |
increases expression |
EXP |
Finasteride results in increased expression of PATJ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:113,061,985...113,364,807
Ensembl chr 5:113,062,118...113,364,807
|
|
G |
Pbdc1 |
polysaccharide biosynthesis domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of PBDC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:70,154,106...70,197,827
Ensembl chr X:70,154,106...70,184,552
|
|
G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of PBLD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
|
|
G |
Pbrm1 |
polybromo 1 |
increases expression |
EXP |
Finasteride results in increased expression of PBRM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
|
|
G |
Pcbp1 |
poly(rC) binding protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of PCBP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:118,972,698...118,974,705
Ensembl chr 4:118,972,661...118,976,500
|
|
G |
Pcbp4 |
poly(rC) binding protein 4 |
increases expression |
EXP |
Finasteride results in increased expression of PCBP4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:107,092,688...107,103,276
Ensembl chr 8:107,093,013...107,103,276
|
|
G |
Pcmtd1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of PCMTD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:12,284,711...12,355,680
Ensembl chr 5:12,284,711...12,354,899
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
Finasteride inhibits the reaction [testosterone enanthate results in increased expression of PCNA protein]; Finasteride inhibits the reaction [Testosterone results in increased expression of PCNA mRNA]; Finasteride inhibits the reaction [Testosterone results in increased expression of PCNA protein] |
CTD |
PMID:25714330 PMID:27687055 PMID:27866977 PMID:36015278 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcd4 |
programmed cell death 4 |
increases expression |
EXP |
Finasteride results in increased expression of PDCD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pdcd7 |
programmed cell death 7 |
increases expression |
EXP |
Finasteride results in increased expression of PDCD7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:65,862,606...65,877,333
Ensembl chr 8:65,862,387...65,877,333
|
|
G |
Pdcl3 |
phosducin-like 3 |
increases expression |
EXP |
Finasteride results in increased expression of PDCL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:41,234,322...41,243,769
Ensembl chr 9:41,234,234...41,243,735
|
|
G |
Pdhx |
pyruvate dehydrogenase complex, component X |
increases expression |
EXP |
Finasteride results in increased expression of PDHX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:89,372,248...89,431,779
Ensembl chr 3:89,371,497...89,431,773
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
increases expression |
EXP |
Finasteride results in increased expression of PDPK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
|
|
G |
Pdxkl1 |
pyridoxal kinase like 1 |
increases expression |
EXP |
Finasteride results in increased expression of PDXKL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:10,162,934...10,192,572
Ensembl chr20:10,164,099...10,192,739
|
|
G |
Pdzd11 |
PDZ domain containing 11 |
increases expression |
EXP |
Finasteride results in increased expression of PDZD11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:65,718,689...65,721,742
Ensembl chr X:65,704,067...65,721,642
|
|
G |
Pef1 |
penta-EF hand domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of PEF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:142,451,791...142,475,061
Ensembl chr 5:142,451,778...142,475,067
|
|
G |
Penk |
proenkephalin |
decreases expression |
EXP |
Finasteride results in decreased expression of PENK mRNA |
CTD |
PMID:19458216 |
|
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
|
|
G |
Per1 |
period circadian regulator 1 |
decreases expression |
EXP |
Finasteride results in decreased expression of PER1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Perp |
p53 apoptosis effector related to PMP22 |
increases expression |
EXP |
Finasteride results in increased expression of PERP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
increases expression |
EXP |
Finasteride results in increased expression of PEX11A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pex14 |
peroxisomal biogenesis factor 14 |
increases expression |
EXP |
Finasteride results in increased expression of PEX14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:159,399,776...159,536,260
Ensembl chr 5:159,399,776...159,536,272
|
|
G |
Pex19 |
peroxisomal biogenesis factor 19 |
increases expression |
EXP |
Finasteride results in increased expression of PEX19 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:84,592,277...84,608,793
Ensembl chr13:84,592,312...84,608,608
|
|
G |
Pex2 |
peroxisomal biogenesis factor 2 |
increases expression |
EXP |
Finasteride results in increased expression of PEX2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:96,050,380...96,072,928
Ensembl chr 2:96,045,958...96,073,404
|
|
G |
Pex5 |
peroxisomal biogenesis factor 5 |
increases expression |
EXP |
Finasteride results in increased expression of PEX5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:157,270,671...157,296,432
Ensembl chr 4:157,270,672...157,296,431
|
|
G |
Pfdn1 |
prefoldin subunit 1 |
increases expression |
EXP |
Finasteride results in increased expression of PFDN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:28,014,145...28,067,148
Ensembl chr18:28,014,145...28,067,064
|
|
G |
Pfdn6 |
prefoldin subunit 6 |
increases expression |
EXP |
Finasteride results in increased expression of PFDN6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,945,959...4,947,433
Ensembl chr20:4,945,959...4,947,433
|
|
G |
Pgap2 |
post-GPI attachment to proteins 2 |
increases expression |
EXP |
Finasteride results in increased expression of PGAP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:156,591,540...156,618,116
Ensembl chr 1:156,591,615...156,618,114
|
|
G |
Pgpep1 |
pyroglutamyl-peptidase I |
increases expression |
EXP |
Finasteride results in increased expression of PGPEP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,770,563...18,782,968
Ensembl chr16:18,771,021...18,783,478
|
|
G |
Pgrmc2 |
progesterone receptor membrane component 2 |
increases expression |
EXP |
Finasteride results in increased expression of PGRMC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:124,068,257...124,084,155
Ensembl chr 2:124,068,260...124,084,155
|
|
G |
Phb1 |
prohibitin 1 |
increases expression |
EXP |
Finasteride results in increased expression of PHB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Phf3 |
PHD finger protein 3 |
increases expression |
EXP |
Finasteride results in increased expression of PHF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:33,063,855...33,136,013
Ensembl chr 9:33,063,857...33,135,994
|
|
G |
Pi4k2b |
phosphatidylinositol 4-kinase type 2 beta |
increases expression |
EXP |
Finasteride results in increased expression of PI4K2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:58,221,790...58,248,716
Ensembl chr14:58,220,437...58,248,673
|
|
G |
Pi4ka |
phosphatidylinositol 4-kinase alpha |
increases expression |
EXP |
Finasteride results in increased expression of PI4KA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:83,609,148...83,726,876
Ensembl chr11:83,609,069...83,724,080
|
|
G |
Pias2 |
protein inhibitor of activated STAT, 2 |
increases expression |
EXP |
Finasteride results in increased expression of PIAS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:70,608,034...70,714,295
Ensembl chr18:70,607,665...70,710,033
|
|
G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
increases expression |
EXP |
Finasteride results in increased expression of PIGC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:74,343,619...74,346,148
Ensembl chr13:74,296,854...74,346,211
|
|
G |
Pigk |
phosphatidylinositol glycan anchor biosynthesis, class K |
increases expression |
EXP |
Finasteride results in increased expression of PIGK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:241,630,021...241,715,493
Ensembl chr 2:241,630,053...241,716,134
|
|
G |
Pigy |
phosphatidylinositol glycan anchor biosynthesis, class Y |
increases expression |
EXP |
Finasteride results in increased expression of PIGY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:20,689,621...20,691,863
Ensembl chr 8:20,689,502...20,692,585
|
|
G |
Pir |
pirin |
increases expression |
EXP |
Finasteride results in increased expression of PIR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
|
|
G |
Pisd |
phosphatidylserine decarboxylase |
increases expression |
EXP |
Finasteride results in increased expression of PISD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:77,941,927...77,991,021
Ensembl chr14:77,941,948...77,991,003
|
|
G |
Pithd1 |
PITH domain containing 1 |
increases expression |
EXP |
Finasteride results in increased expression of PITHD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:148,205,995...148,216,490
Ensembl chr 5:148,205,998...148,217,080
|
|
G |
Pitrm1 |
pitrilysin metallopeptidase 1 |
increases expression |
EXP |
Finasteride results in increased expression of PITRM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:63,795,670...63,827,317
Ensembl chr17:63,795,671...63,839,907
|
|
G |
Pja2 |
praja ring finger ubiquitin ligase 2 |
increases expression |
EXP |
Finasteride results in increased expression of PJA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:103,956,678...104,006,763
Ensembl chr 9:103,956,678...104,006,783
|
|
G |
Pla2g15 |
phospholipase A2, group XV |
increases expression |
EXP |
Finasteride results in increased expression of PLA2G15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:34,050,685...34,068,070
Ensembl chr19:34,050,694...34,068,063
|
|
G |
Plec |
plectin |
increases expression |
EXP |
Finasteride results in increased expression of PLEC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:107,887,764...107,949,100
Ensembl chr 7:107,887,764...107,945,467
|
|
G |
Plekhb2 |
pleckstrin homology domain containing B2 |
increases expression |
EXP |
Finasteride results in increased expression of PLEKHB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:37,049,580...37,082,231
Ensembl chr 9:37,038,751...37,082,231
|
|
G |
Plin3 |
perilipin 3 |
increases expression |
EXP |
Finasteride results in increased expression of PLIN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Plod1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
increases expression |
EXP |
Finasteride results in increased expression of PLOD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:158,340,674...158,367,581
Ensembl chr 5:158,340,490...158,367,620
|
|
G |
Plp2 |
proteolipid protein 2 |
increases expression |
EXP |
Finasteride results in increased expression of PLP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:14,834,249...14,837,648
Ensembl chr X:14,834,231...14,838,514
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
increases expression |
EXP |
Finasteride results in increased expression of PLPP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
|
|
G |
Pmm1 |
phosphomannomutase 1 |
increases expression |
EXP |
Finasteride results in increased expression of PMM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:113,466,632...113,477,004
Ensembl chr 7:113,466,632...113,477,022
|
|
G |
Pmpcb |
peptidase, mitochondrial processing subunit beta |
increases expression |
EXP |
Finasteride results in increased expression of PMPCB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:13,297,583...13,310,363
Ensembl chr 4:13,297,559...13,310,367
|
|
G |
Pno1 |
partner of NOB1 homolog |
increases expression |
EXP |
Finasteride results in increased expression of PNO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:91,609,711...91,618,280
Ensembl chr14:91,609,233...91,618,324
|
|
G |
Pnpla8 |
patatin-like phospholipase domain containing 8 |
increases expression |
EXP |
Finasteride results in increased expression of PNPLA8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:61,329,810...61,391,736
Ensembl chr 6:61,329,810...61,391,734
|
|
G |
Pnpt1 |
polyribonucleotide nucleotidyltransferase 1 |
increases expression |
EXP |
Finasteride results in increased expression of PNPT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:102,877,553...102,908,696
Ensembl chr14:102,877,553...102,908,696
|
|
G |
Pold3 |
DNA polymerase delta 3, accessory subunit |
increases expression |
EXP |
Finasteride results in increased expression of POLD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:154,417,893...154,456,687
Ensembl chr 1:154,418,084...154,456,665
|
|
G |
Pole3 |
DNA polymerase epsilon 3, accessory subunit |
increases expression |
EXP |
Finasteride results in increased expression of POLE3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:75,973,941...75,977,175
Ensembl chr 5:75,974,717...75,977,231 Ensembl chr 7:75,974,717...75,977,231
|
|
G |
Pole4 |
DNA polymerase epsilon 4, accessory subunit |
increases expression |
EXP |
Finasteride results in increased expression of POLE4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,165,285...115,171,097
Ensembl chr 4:115,165,285...115,171,097
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
increases expression |
EXP |
Finasteride results in increased expression of POLG mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
|
|
G |
Polr2c |
RNA polymerase II subunit C |
increases expression |
EXP |
Finasteride results in increased expression of POLR2C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,158,153...10,164,935
Ensembl chr19:10,157,823...10,164,945
|
|
G |
Polr2f |
RNA polymerase II, I and III subunit F |
increases expression |
EXP |
Finasteride results in increased expression of POLR2F mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:110,712,528...110,724,234
Ensembl chr 7:110,712,572...110,724,234
|
|
G |
Polr2i |
RNA polymerase II subunit I |
increases expression |
EXP |
Finasteride results in increased expression of POLR2I mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:85,483,515...85,484,952
Ensembl chr 1:85,483,515...85,484,952
|
|
G |
Polr2m |
RNA polymerase II subunit M |
increases expression |
EXP |
Finasteride results in increased expression of POLR2M mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:72,131,992...72,139,423
Ensembl chr 8:72,131,530...72,243,036
|
|
G |
Polr3k |
RNA polymerase III subunit K |
increases expression |
EXP |
Finasteride results in increased expression of POLR3K mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:168,982,846...168,987,043
Ensembl chr 3:168,982,812...168,987,040
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions |
ISO |
[Finasteride results in increased susceptibility to IL1B protein] which results in increased secretion of POMC protein |
CTD |
PMID:19458216 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pomp |
proteasome maturation protein |
increases expression |
EXP |
Finasteride results in increased expression of POMP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:7,162,098...7,174,737
Ensembl chr12:7,160,714...7,174,715
|
|
G |
Pomt1 |
protein-O-mannosyltransferase 1 |
increases expression |
EXP |
Finasteride results in increased expression of POMT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:15,520,717...15,538,579
Ensembl chr 3:15,520,481...15,538,581
|
|
G |
Pon3 |
paraoxonase 3 |
decreases expression |
EXP |
Finasteride results in decreased expression of PON3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
Finasteride binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppcs |
phosphopantothenoylcysteine synthetase |
increases expression |
EXP |
Finasteride results in increased expression of PPCS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:133,023,077...133,026,899
Ensembl chr 5:133,023,121...133,026,933
|
|
G |
Ppfibp1 |
PPFIA binding protein 1 |
increases expression |
EXP |
Finasteride results in increased expression of PPFIBP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:179,807,579...179,951,428
Ensembl chr 4:179,808,794...179,951,428
|
|
G |
Ppp1r11 |
protein phosphatase 1, regulatory (inhibitor) subunit 11 |
increases expression |
EXP |
Finasteride results in increased expression of PPP1R11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:1,601,350...1,604,857
Ensembl chr20:1,601,346...1,604,846
|
|
G |
Ppp1r21 |
protein phosphatase 1, regulatory subunit 21 |
increases expression |
EXP |
Finasteride results in increased expression of PPP1R21 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:5,901,518...5,970,684
Ensembl chr 6:5,901,518...5,970,684
|
|
G |
Ppp2cb |
protein phosphatase 2 catalytic subunit beta |
increases expression |
EXP |
Finasteride results in increased expression of PPP2CB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:58,558,119...58,579,325
Ensembl chr1 | |